Perspectives on Systems Biology Applications in Diabetic Kidney Disease

go back to reference Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes. Diabetes Care, 27(5), 1047–1053.PubMedCrossRef Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004). Global prevalence of diabetes. Diabetes Care, 27(5), 1047–1053.PubMedCrossRef

go back to reference Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 87(1), 4–14.PubMedCrossRef Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract, 87(1), 4–14.PubMedCrossRef

go back to reference Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007). Prevalence of chronic kidney disease in the United States. JAMA, 298(17), 2038–2047.PubMedCrossRef Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007). Prevalence of chronic kidney disease in the United States. JAMA, 298(17), 2038–2047.PubMedCrossRef

go back to reference Foley, R., & Collins, A. (2009). The growing economic burden of diabetic kidney disease. Curr Diab Rep, 9(6), 460–465.PubMedCrossRef Foley, R., & Collins, A. (2009). The growing economic burden of diabetic kidney disease. Curr Diab Rep, 9(6), 460–465.PubMedCrossRef

go back to reference The Australia and New Zealand Dialysis and Transplant Registry (2011) The 34th Annual ANZDATA Report 2011—Data to 2010. At: http://wwwanzdataorgau/v1/report_2011html. Accessed March 30, 2012. The Australia and New Zealand Dialysis and Transplant Registry (2011) The 34th Annual ANZDATA Report 2011—Data to 2010. At: http://​wwwanzdataorgau/​v1/​report_​2011html. Accessed March 30, 2012.

go back to reference European Renal Association—European Dialysis and Transplant (ERA-EDTA) Registry (2011) ERA-EDTA registry annual report 2009. At: http://wwwera-edta-regorg/files/annualreports/pdf/AnnRep2009_newpdf. Accessed March 30, 2012 European Renal Association—European Dialysis and Transplant (ERA-EDTA) Registry (2011) ERA-EDTA registry annual report 2009. At: http://​wwwera-edta-regorg/​files/​annualreports/​pdf/​AnnRep2009_​newpdf. Accessed March 30, 2012

go back to reference US Renal Data System (2011) USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. At: http://www.usrds.org. Accessed 22 March 2012. US Renal Data System (2011) USRDS 2011 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. At: http://​www.​usrds.​org. Accessed 22 March 2012.

go back to reference de Boer, I. H., Rue, T. C., Hall, Y. N., Heagerty, P. J., Weiss, N. S., & Himmelfarb, J. (2011). Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA, 305(24), 2532–2539.PubMedCrossRef de Boer, I. H., Rue, T. C., Hall, Y. N., Heagerty, P. J., Weiss, N. S., & Himmelfarb, J. (2011). Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA, 305(24), 2532–2539.PubMedCrossRef

go back to reference Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl J Med, 339(4), 229–234.PubMedCrossRef Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl J Med, 339(4), 229–234.PubMedCrossRef

go back to reference Valmadrid, C. T., Klein, R., Moss, S. E., & Klein, B. E. K. (2000). The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med, 160(8), 1093–1100.PubMedCrossRef Valmadrid, C. T., Klein, R., Moss, S. E., & Klein, B. E. K. (2000). The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med, 160(8), 1093–1100.PubMedCrossRef

go back to reference Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., & Wilson, P. W. (2003). Kidney disease as a risk factor for development of cardiovascular disease. Hypertension, 42(5), 1050–1065.PubMedCrossRef Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., & Wilson, P. W. (2003). Kidney disease as a risk factor for development of cardiovascular disease. Hypertension, 42(5), 1050–1065.PubMedCrossRef

go back to reference Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865), 813–820.PubMedCrossRef Brownlee, M. (2001). Biochemistry and molecular cell biology of diabetic complications. Nature, 414(6865), 813–820.PubMedCrossRef

go back to reference Forbes, J. M., Fukami, K., & Cooper, M. E. (2007). Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes, 115(2), 69–84.PubMedCrossRef Forbes, J. M., Fukami, K., & Cooper, M. E. (2007). Diabetic nephropathy: where hemodynamics meets metabolism. Exp Clin Endocrinol Diabetes, 115(2), 69–84.PubMedCrossRef

go back to reference Figueroa-Romero, C., Sadidi, M., & Feldman, E. (2008). Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord, 9(4), 301–314.PubMedCrossRef Figueroa-Romero, C., Sadidi, M., & Feldman, E. (2008). Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord, 9(4), 301–314.PubMedCrossRef

go back to reference Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., Argetsinger, L. S., Rastaldi, M. P., Brosius, F. C., & Kretzler, M. (2009). Enhanced expression of Janus kinase and signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes, 58(2), 469–477.PubMedCrossRef Berthier, C. C., Zhang, H., Schin, M., Henger, A., Nelson, R. G., Yee, B., Boucherot, A., Neusser, M. A., Cohen, C. D., Carter-Su, C., Argetsinger, L. S., Rastaldi, M. P., Brosius, F. C., & Kretzler, M. (2009). Enhanced expression of Janus kinase and signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes, 58(2), 469–477.PubMedCrossRef

go back to reference Navarro, J. F., & Mora-Fernández, C. (2006). The role of TNF-α in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev, 17(6), 441–450.PubMedCrossRef Navarro, J. F., & Mora-Fernández, C. (2006). The role of TNF-α in diabetic nephropathy: pathogenic and therapeutic implications. Cytokine Growth Factor Rev, 17(6), 441–450.PubMedCrossRef

go back to reference Williams, M. E. (2005). Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol, 25(2), 77–94.PubMedCrossRef Williams, M. E. (2005). Diabetic nephropathy: the proteinuria hypothesis. Am J Nephrol, 25(2), 77–94.PubMedCrossRef

go back to reference Schena, F. P., & Gesualdo, L. (2005). Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol, 16(3_suppl_1), S30–S33.PubMedCrossRef Schena, F. P., & Gesualdo, L. (2005). Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol, 16(3_suppl_1), S30–S33.PubMedCrossRef

go back to reference Galkina, E., & Ley, K. (2006). Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol, 17(2), 368–377.PubMedCrossRef Galkina, E., & Ley, K. (2006). Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol, 17(2), 368–377.PubMedCrossRef

go back to reference Nawroth, P. P., & Isermann, B. (2010). Mechanisms of diabetic nephropathy—old buddies and newcomers part 2. Exp Clin Endocrinol Diabetes, 118(10), 667–672.PubMedCrossRef Nawroth, P. P., & Isermann, B. (2010). Mechanisms of diabetic nephropathy—old buddies and newcomers part 2. Exp Clin Endocrinol Diabetes, 118(10), 667–672.PubMedCrossRef

go back to reference Nawroth, P. P., & Isermann, B. (2010). Mechanisms of diabetic nephropathy—old buddies and newcomers part 1. Exp Clin Endocrinol Diabetes, 118(9), 571–576.PubMedCrossRef Nawroth, P. P., & Isermann, B. (2010). Mechanisms of diabetic nephropathy—old buddies and newcomers part 1. Exp Clin Endocrinol Diabetes, 118(9), 571–576.PubMedCrossRef

go back to reference Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011). A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol, 6(1), 395–423.PubMedCrossRef Kanwar, Y. S., Sun, L., Xie, P., Liu, F.-Y., & Chen, S. (2011). A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu Rev Pathol, 6(1), 395–423.PubMedCrossRef

go back to reference DiBona, G. F., & Kopp, U. C. (1997). Neural control of renal function. Physiol Rev, 77(1), 75–197.PubMed DiBona, G. F., & Kopp, U. C. (1997). Neural control of renal function. Physiol Rev, 77(1), 75–197.PubMed

go back to reference Augustyniak, R. A., Tuncel, M., Zhang, W., Toto, R. D., & Victor, R. G. (2002). Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens, 20(1), 3–9.PubMedCrossRef Augustyniak, R. A., Tuncel, M., Zhang, W., Toto, R. D., & Victor, R. G. (2002). Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens, 20(1), 3–9.PubMedCrossRef

go back to reference Grotendorst, G. R. (1997). Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev, 8(3), 171–179.PubMedCrossRef Grotendorst, G. R. (1997). Connective tissue growth factor: a mediator of TGF-β action on fibroblasts. Cytokine Growth Factor Rev, 8(3), 171–179.PubMedCrossRef

go back to reference Böttinger, E. P., & Bitzer, M. (2002). TGF-ß signaling in renal disease. J Am Soc Nephrol, 13(10), 2600–2610.PubMedCrossRef Böttinger, E. P., & Bitzer, M. (2002). TGF-ß signaling in renal disease. J Am Soc Nephrol, 13(10), 2600–2610.PubMedCrossRef

go back to reference Liu, Y. (2006). Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int, 69(2), 213–217.PubMedCrossRef Liu, Y. (2006). Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int, 69(2), 213–217.PubMedCrossRef

go back to reference Froissart, M., Rossert, J., Jacquot, C., Paillard, M., & Houillier, P. (2005). Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol, 16(3), 763–773.PubMedCrossRef Froissart, M., Rossert, J., Jacquot, C., Paillard, M., & Houillier, P. (2005). Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol, 16(3), 763–773.PubMedCrossRef

go back to reference Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006). Assessing kidney function—measured and estimated glomerular filtration rate. New Engl J Med, 354(23), 2473–2483.PubMedCrossRef Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006). Assessing kidney function—measured and estimated glomerular filtration rate. New Engl J Med, 354(23), 2473–2483.PubMedCrossRef

go back to reference Stevens, L. A., & Levey, A. S. (2009). Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol, 20(11), 2305–2313.PubMedCrossRef Stevens, L. A., & Levey, A. S. (2009). Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol, 20(11), 2305–2313.PubMedCrossRef

go back to reference Stevens, L. A., Schmid, C. H., Greene, T., Zhang, Y., Beck, G. J., Froissart, M., Hamm, L. L., Lewis, J. B., Mauer, M., Navis, G. J., Steffes, M. W., Eggers, P. W., Coresh, J., & Levey, A. S. (2010). Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2. Am J Kidney Dis, 56(3), 486–495.PubMedCrossRef Stevens, L. A., Schmid, C. H., Greene, T., Zhang, Y., Beck, G. J., Froissart, M., Hamm, L. L., Lewis, J. B., Mauer, M., Navis, G. J., Steffes, M. W., Eggers, P. W., Coresh, J., & Levey, A. S. (2010). Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m². Am J Kidney Dis, 56(3), 486–495.PubMedCrossRef

go back to reference Levey, A. S., Cattran, D., Friedman, A., Miller, W. G., Sedor, J., Tuttle, K., Kasiske, B., & Hostetter, T. (2009). Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis, 54(2), 205–226.PubMedCrossRef Levey, A. S., Cattran, D., Friedman, A., Miller, W. G., Sedor, J., Tuttle, K., Kasiske, B., & Hostetter, T. (2009). Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis, 54(2), 205–226.PubMedCrossRef

go back to reference Julian, B. A., Suzuki, H., Suzuki, Y., Tomino, Y., Spasovski, G., & Novak, J. (2009). Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease. Proteomics Clin Appl, 3(9), 1029–1043.PubMedCrossRef Julian, B. A., Suzuki, H., Suzuki, Y., Tomino, Y., Spasovski, G., & Novak, J. (2009). Sources of urinary proteins and their analysis by urinary proteomics for the detection of biomarkers of disease. Proteomics Clin Appl, 3(9), 1029–1043.PubMedCrossRef

go back to reference Caramori, M. L., Fioretto, P., & Mauer, M. (2000). The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes, 49(9), 1399–1408.PubMedCrossRef Caramori, M. L., Fioretto, P., & Mauer, M. (2000). The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient? Diabetes, 49(9), 1399–1408.PubMedCrossRef

go back to reference Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003). Regression of microalbuminuria in type 1 diabetes. New Engl J Med, 348(23), 2285–2293.PubMedCrossRef Perkins, B. A., Ficociello, L. H., Silva, K. H., Finkelstein, D. M., Warram, J. H., & Krolewski, A. S. (2003). Regression of microalbuminuria in type 1 diabetes. New Engl J Med, 348(23), 2285–2293.PubMedCrossRef

go back to reference Fioretto, P., & Mauer, M. (2007). Histopathology of diabetic nephropathy. Semin Nephrol, 27(2), 195–207.PubMedCrossRef Fioretto, P., & Mauer, M. (2007). Histopathology of diabetic nephropathy. Semin Nephrol, 27(2), 195–207.PubMedCrossRef

go back to reference American Diabetes Association. (2011). Standards of medical care in diabetes—2011. Diabetes Care, 34(Supplement 1), S11–S61.CrossRef American Diabetes Association. (2011). Standards of medical care in diabetes—2011. Diabetes Care, 34(Supplement 1), S11–S61.CrossRef

go back to reference Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007). Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol, 18(4), 1353–1361.PubMedCrossRef Perkins, B. A., Ficociello, L. H., Ostrander, B. E., Silva, K. H., Weinberg, J., Warram, J. H., & Krolewski, A. S. (2007). Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes. J Am Soc Nephrol, 18(4), 1353–1361.PubMedCrossRef

go back to reference Perkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H., & Krolewski, A. S. (2010). In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int, 77(1), 57–64.PubMedCrossRef Perkins, B. A., Ficociello, L. H., Roshan, B., Warram, J. H., & Krolewski, A. S. (2010). In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. Kidney Int, 77(1), 57–64.PubMedCrossRef

go back to reference MacIsaac, R., & Jerums, G. (2011). Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens, 20(3), 246–257.PubMedCrossRef MacIsaac, R., & Jerums, G. (2011). Diabetic kidney disease with and without albuminuria. Curr Opin Nephrol Hypertens, 20(3), 246–257.PubMedCrossRef

go back to reference Dwyer, J. P., Parving, H. H., Hunsicker, L. G., Ravid, M., Remuzzi, G., & Lewis, J. B. (2012). Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study. Cardiorenal Medicine, 2(1), 1–10.PubMedCrossRef Dwyer, J. P., Parving, H. H., Hunsicker, L. G., Ravid, M., Remuzzi, G., & Lewis, J. B. (2012). Renal dysfunction in the presence of normoalbuminuria in type 2 diabetes: results from the DEMAND study. Cardiorenal Medicine, 2(1), 1–10.PubMedCrossRef

go back to reference Pavkov, M. E., Knowler, W. C., Lemley, K. V., Mason, C. C., Myers, B. D., & Nelson, R. G. (2012). Early renal function decline in type 2 diabetes. Clin J Am Soc Nephrol, 7(1), 78–84.PubMedCrossRef Pavkov, M. E., Knowler, W. C., Lemley, K. V., Mason, C. C., Myers, B. D., & Nelson, R. G. (2012). Early renal function decline in type 2 diabetes. Clin J Am Soc Nephrol, 7(1), 78–84.PubMedCrossRef

go back to reference Karalliedde, J., & Viberti, G. (2010). Proteinuria in diabetes: bystander or pathway to cardiorenal disease? J Am Soc Nephrol, 21(12), 2020–2027.PubMedCrossRef Karalliedde, J., & Viberti, G. (2010). Proteinuria in diabetes: bystander or pathway to cardiorenal disease? J Am Soc Nephrol, 21(12), 2020–2027.PubMedCrossRef

go back to reference Tryggvason, K., & Pettersson, E. (2003). Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. J Intern Med, 254(3), 216–224.PubMedCrossRef Tryggvason, K., & Pettersson, E. (2003). Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure. J Intern Med, 254(3), 216–224.PubMedCrossRef

go back to reference Iyengar, S. K., Schelling, J. R., & Sedor, J. R. (2002). Approaches to understanding susceptibility to nephropathy: from genetics to genomics. Kidney Int, 61(Suppl. 1), S61–S67.PubMedCrossRef Iyengar, S. K., Schelling, J. R., & Sedor, J. R. (2002). Approaches to understanding susceptibility to nephropathy: from genetics to genomics. Kidney Int, 61(Suppl. 1), S61–S67.PubMedCrossRef

go back to reference Iyengar, S. K., Abboud, H. E., Goddard, K. A. B., Saad, M. F., Adler, S. G., Arar, N. H., Bowden, D. W., Duggirala, R., Elston, R. C., Hanson, R. L., Ipp, E., Kao, W. H. L., Kimmel, P. L., Klag, M. J., Knowler, W. C., Meoni, L. A., Nelson, R. G., Nicholas, S. B., Pahl, M. V., Parekh, R. S., Quade, S. R. E., Rich, S. S., Rotter, J. I., Scavini, M., Schelling, J. R., Sedor, J. R., Sehgal, A. R., Shah, V. O., Smith, M. W., Taylor, K. D., Winkler, C. A., Zager, P. G., & Freedman, B. I. (2007). Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: The Family Investigation of Nephropathy and Diabetes (FIND). Diabetes, 56(6), 1577–1585.PubMedCrossRef Iyengar, S. K., Abboud, H. E., Goddard, K. A. B., Saad, M. F., Adler, S. G., Arar, N. H., Bowden, D. W., Duggirala, R., Elston, R. C., Hanson, R. L., Ipp, E., Kao, W. H. L., Kimmel, P. L., Klag, M. J., Knowler, W. C., Meoni, L. A., Nelson, R. G., Nicholas, S. B., Pahl, M. V., Parekh, R. S., Quade, S. R. E., Rich, S. S., Rotter, J. I., Scavini, M., Schelling, J. R., Sedor, J. R., Sehgal, A. R., Shah, V. O., Smith, M. W., Taylor, K. D., Winkler, C. A., Zager, P. G., & Freedman, B. I. (2007). Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: The Family Investigation of Nephropathy and Diabetes (FIND). Diabetes, 56(6), 1577–1585.PubMedCrossRef

go back to reference Igo, J. R. P., Iyengar, S. K., Nicholas, S. B., Goddard, K. A. B., Langefeld, C. D., Hanson, R. L., Duggirala, R., Divers, J., Abboud, H., Adler, S. G., Arar, N. H., Horvath, A., Elston, R. C., Bowden, D. W., Guo, X., Ipp, E., Kao, W. H. L., Kimmel, P. L., Knowler, W. C., Meoni, L. A., Molineros, J., Nelson, R. G., Pahl, M. V., Parekh, R. S., Rasooly, R. S., Schelling, J. R., Shah, V. O., Smith, M. W., Winkler, C. A., Zager, P. G., Sedor, J. R., Freedman, B. I., & The Family Investigation of Nephropathy and Diabetes Research Group. (2011). Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol., 33(5), 381–389.PubMedCrossRef Igo, J. R. P., Iyengar, S. K., Nicholas, S. B., Goddard, K. A. B., Langefeld, C. D., Hanson, R. L., Duggirala, R., Divers, J., Abboud, H., Adler, S. G., Arar, N. H., Horvath, A., Elston, R. C., Bowden, D. W., Guo, X., Ipp, E., Kao, W. H. L., Kimmel, P. L., Knowler, W. C., Meoni, L. A., Molineros, J., Nelson, R. G., Pahl, M. V., Parekh, R. S., Rasooly, R. S., Schelling, J. R., Shah, V. O., Smith, M. W., Winkler, C. A., Zager, P. G., Sedor, J. R., Freedman, B. I., & The Family Investigation of Nephropathy and Diabetes Research Group. (2011). Genomewide linkage scan for diabetic renal failure and albuminuria: the FIND study. Am J Nephrol., 33(5), 381–389.PubMedCrossRef

go back to reference Gohda, T., Tanimoto, M., Watanabe-Yamada, K., Matsumoto, M., Kaneko, S., Hagiwara, S., Shiina, K., Shike, T., Funabiki, K., & Tomino, Y. (2005). Genetic susceptibility to type 2 diabetic nephropathy in human and animal models. Nephrology, 10(Supplement s2), S22–S25.PubMedCrossRef Gohda, T., Tanimoto, M., Watanabe-Yamada, K., Matsumoto, M., Kaneko, S., Hagiwara, S., Shiina, K., Shike, T., Funabiki, K., & Tomino, Y. (2005). Genetic susceptibility to type 2 diabetic nephropathy in human and animal models. Nephrology, 10(Supplement s2), S22–S25.PubMedCrossRef

go back to reference Tanaka, N., & Babazono, T. (2005). Assessing genetic susceptibility to diabetic nephropathy. Nephrology, 10(Supplement s2), S17–S21.PubMedCrossRef Tanaka, N., & Babazono, T. (2005). Assessing genetic susceptibility to diabetic nephropathy. Nephrology, 10(Supplement s2), S17–S21.PubMedCrossRef

go back to reference Mueller, P. W., Rogus, J. J., Cleary, P. A., Zhao, Y., Smiles, A. M., Steffes, M. W., Bucksa, J., Gibson, T. B., Cordovado, S. K., Krolewski, A. S., Nierras, C. R., & Warram, J. H. (2006). Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol, 17(7), 1782–1790.PubMedCrossRef Mueller, P. W., Rogus, J. J., Cleary, P. A., Zhao, Y., Smiles, A. M., Steffes, M. W., Bucksa, J., Gibson, T. B., Cordovado, S. K., Krolewski, A. S., Nierras, C. R., & Warram, J. H. (2006). Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. J Am Soc Nephrol, 17(7), 1782–1790.PubMedCrossRef

go back to reference Freedman, B. I., Bostrom, M., Daeihagh, P., & Bowden, D. W. (2007). Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol, 2(6), 1306–1316.PubMedCrossRef Freedman, B. I., Bostrom, M., Daeihagh, P., & Bowden, D. W. (2007). Genetic factors in diabetic nephropathy. Clin J Am Soc Nephrol, 2(6), 1306–1316.PubMedCrossRef

go back to reference Conway, B. R., & Maxwell, A. P. (2009). Genetics of diabetic nephropathy: are there clues to the understanding of common kidney diseases? Nephron Clin Pract, 112(4), c213–c221.PubMedCrossRef Conway, B. R., & Maxwell, A. P. (2009). Genetics of diabetic nephropathy: are there clues to the understanding of common kidney diseases? Nephron Clin Pract, 112(4), c213–c221.PubMedCrossRef

go back to reference Pezzolesi, M. G., Poznik, G. D., Mychaleckyj, J. C., Paterson, A. D., Barati, M. T., Klein, J. B., Ng, D. P. K., Placha, G., Canani, L. H., Bochenski, J., Waggott, D., Merchant, M. L., Krolewski, B., Mirea, L., Wanic, K., Katavetin, P., Kure, M., Wolkow, P., Dunn, J. S., Smiles, A., Walker, W. H., Boright, A. P., Bull, S. B., the DCCT/EDIC Research Group, Doria, A., Rogus, J. J., Rich, S. S., Warram, J. H., & Krolewski, A. S. (2009). Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes, 58(6), 1403–1410.PubMedCrossRef Pezzolesi, M. G., Poznik, G. D., Mychaleckyj, J. C., Paterson, A. D., Barati, M. T., Klein, J. B., Ng, D. P. K., Placha, G., Canani, L. H., Bochenski, J., Waggott, D., Merchant, M. L., Krolewski, B., Mirea, L., Wanic, K., Katavetin, P., Kure, M., Wolkow, P., Dunn, J. S., Smiles, A., Walker, W. H., Boright, A. P., Bull, S. B., the DCCT/EDIC Research Group, Doria, A., Rogus, J. J., Rich, S. S., Warram, J. H., & Krolewski, A. S. (2009). Genome-wide association scan for diabetic nephropathy susceptibility genes in type 1 diabetes. Diabetes, 58(6), 1403–1410.PubMedCrossRef

go back to reference Pezzolesi, M. G., Skupien, J., Mychaleckyj, J. C., Warram, J. H., & Krolewski, A. S. (2010). Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD Collection. Semin Nephrol, 30(2), 126–140.PubMedCrossRef Pezzolesi, M. G., Skupien, J., Mychaleckyj, J. C., Warram, J. H., & Krolewski, A. S. (2010). Insights to the genetics of diabetic nephropathy through a genome-wide association study of the GoKinD Collection. Semin Nephrol, 30(2), 126–140.PubMedCrossRef

go back to reference Schadt, E. E., Sachs, A., & Friend, S. (2005). Embracing complexity, inching closer to reality. Sci STKE, 2005(295), pe40.PubMedCrossRef Schadt, E. E., Sachs, A., & Friend, S. (2005). Embracing complexity, inching closer to reality. Sci STKE, 2005(295), pe40.PubMedCrossRef

go back to reference Dobrin, R., Zhu, J., Molony, C., Argman, C., Parrish, M., Carlson, S., Allan, M., Pomp, D., & Schadt, E. (2009). Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease. Genome Biol, 10(5), R55.PubMedCrossRef Dobrin, R., Zhu, J., Molony, C., Argman, C., Parrish, M., Carlson, S., Allan, M., Pomp, D., & Schadt, E. (2009). Multi-tissue coexpression networks reveal unexpected subnetworks associated with disease. Genome Biol, 10(5), R55.PubMedCrossRef

go back to reference Sauer, U., Heinemann, M., & Zamboni, N. (2007). Getting closer to the whole picture. Science, 316(5824), 550–551.PubMedCrossRef Sauer, U., Heinemann, M., & Zamboni, N. (2007). Getting closer to the whole picture. Science, 316(5824), 550–551.PubMedCrossRef

go back to reference Chuang, H.-Y., Hofree, M., & Ideker, T. (2010). A decade of systems biology. Annu Rev Cell Dev Biol, 26(1), 721–744.PubMedCrossRef Chuang, H.-Y., Hofree, M., & Ideker, T. (2010). A decade of systems biology. Annu Rev Cell Dev Biol, 26(1), 721–744.PubMedCrossRef

go back to reference Houle, D., Govindaraju, D. R., & Omholt, S. (2010). Phenomics: the next challenge. Nat Rev Genet, 11(12), 855–866.PubMedCrossRef Houle, D., Govindaraju, D. R., & Omholt, S. (2010). Phenomics: the next challenge. Nat Rev Genet, 11(12), 855–866.PubMedCrossRef

go back to reference Haring, R., and Wallaschofski, H. (2012) Diving through the “-Omics”: the case for deep phenotyping and systems epidemiology. OMICS: J Integrative Biol 16 (in press) (Epub ahead of print: February 9, 2012). Haring, R., and Wallaschofski, H. (2012) Diving through the “-Omics”: the case for deep phenotyping and systems epidemiology. OMICS: J Integrative Biol 16 (in press) (Epub ahead of print: February 9, 2012).

go back to reference Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J. E., Shah, R. B., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2005). Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 310(5748), 644–648.PubMedCrossRef Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., Lee, C., Montie, J. E., Shah, R. B., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2005). Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science, 310(5748), 644–648.PubMedCrossRef

go back to reference Hamburg, M. A., & Collins, F. S. (2010). The path to personalized medicine. New Engl J Med, 363(4), 301–304.PubMedCrossRef Hamburg, M. A., & Collins, F. S. (2010). The path to personalized medicine. New Engl J Med, 363(4), 301–304.PubMedCrossRef

go back to reference Allison, M. (2008). Is personalized medicine finally arriving? Nat Biotechnol, 26(5), 509–517.PubMedCrossRef Allison, M. (2008). Is personalized medicine finally arriving? Nat Biotechnol, 26(5), 509–517.PubMedCrossRef

go back to reference Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989). Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. New Engl J Med, 320(18), 1161–1165.PubMedCrossRef Seaquist, E. R., Goetz, F. C., Rich, S., & Barbosa, J. (1989). Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. New Engl J Med, 320(18), 1161–1165.PubMedCrossRef

go back to reference Borch-Johnsen, K., Norgaard, K., Hommel, E., Mathiesen, E. R., Jensen, J. S., Deckert, T., & Parving, H.-H. (1992). Is diabetic nephropathy an inherited complication? Kidney Int, 41(4), 719–722.PubMedCrossRef Borch-Johnsen, K., Norgaard, K., Hommel, E., Mathiesen, E. R., Jensen, J. S., Deckert, T., & Parving, H.-H. (1992). Is diabetic nephropathy an inherited complication? Kidney Int, 41(4), 719–722.PubMedCrossRef

go back to reference Imperatore, G., Knowler, W. C., Pettitt, D. J., Kobes, S., Bennett, P. H., & Hanson, R. L. (2000). Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes, 49(6), 1049–1056.PubMedCrossRef Imperatore, G., Knowler, W. C., Pettitt, D. J., Kobes, S., Bennett, P. H., & Hanson, R. L. (2000). Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes, 49(6), 1049–1056.PubMedCrossRef

go back to reference Knowler, W. C., Coresh, J., Elston, R. C., Freedman, B. I., Iyengar, S. K., Kimmel, P. L., Olson, J. M., Plaetke, R., Sedor, J. R., & Seldin, M. F. (2005). The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. J Diabetes Complications, 19(1), 1–9.PubMedCrossRef Knowler, W. C., Coresh, J., Elston, R. C., Freedman, B. I., Iyengar, S. K., Kimmel, P. L., Olson, J. M., Plaetke, R., Sedor, J. R., & Seldin, M. F. (2005). The Family Investigation of Nephropathy and Diabetes (FIND): design and methods. J Diabetes Complications, 19(1), 1–9.PubMedCrossRef

go back to reference Pezzolesi, M. G., Poznik, G. D., Skupien, J., Smiles, A. M., Mychaleckyj, J. C., Rich, S. S., Warram, J. H., & Krolewski, A. S. (2011). An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes. Kidney Int, 80(1), 105–111.PubMedCrossRef Pezzolesi, M. G., Poznik, G. D., Skupien, J., Smiles, A. M., Mychaleckyj, J. C., Rich, S. S., Warram, J. H., & Krolewski, A. S. (2011). An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes. Kidney Int, 80(1), 105–111.PubMedCrossRef

go back to reference Mooyaart, A., Valk, E., van Es, L., Bruijn, J., de Heer, E., Freedman, B., Dekkers, O., & Baelde, H. (2011). Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia, 54(3), 544–553.PubMedCrossRef Mooyaart, A., Valk, E., van Es, L., Bruijn, J., de Heer, E., Freedman, B., Dekkers, O., & Baelde, H. (2011). Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia, 54(3), 544–553.PubMedCrossRef

go back to reference Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., Cho, J. H., Guttmacher, A. E., Kong, A., Kruglyak, L., Mardis, E., Rotimi, C. N., Slatkin, M., Valle, D., Whittemore, A. S., Boehnke, M., Clark, A. G., Eichler, E. E., Gibson, G., Haines, J. L., Mackay, T. F. C., McCarroll, S. A., & Visscher, P. M. (2009). Finding the missing heritability of complex diseases. Nature, 461(7265), 747–753.PubMedCrossRef Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., Cho, J. H., Guttmacher, A. E., Kong, A., Kruglyak, L., Mardis, E., Rotimi, C. N., Slatkin, M., Valle, D., Whittemore, A. S., Boehnke, M., Clark, A. G., Eichler, E. E., Gibson, G., Haines, J. L., Mackay, T. F. C., McCarroll, S. A., & Visscher, P. M. (2009). Finding the missing heritability of complex diseases. Nature, 461(7265), 747–753.PubMedCrossRef

go back to reference Zuk, O., Hechter, E., Sunyaev, S. R., & Lander, E. S. (2012). The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA, 109(4), 1193–1198.PubMedCrossRef Zuk, O., Hechter, E., Sunyaev, S. R., & Lander, E. S. (2012). The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci USA, 109(4), 1193–1198.PubMedCrossRef

go back to reference McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet, 9(5), 356–369.PubMedCrossRef McCarthy, M. I., Abecasis, G. R., Cardon, L. R., Goldstein, D. B., Little, J., Ioannidis, J. P. A., & Hirschhorn, J. N. (2008). Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet, 9(5), 356–369.PubMedCrossRef

go back to reference Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., Bernhardy, A. J., Hicks, P. J., Nelson, G. W., Vanhollebeke, B., Winkler, C. A., Kopp, J. B., Pays, E., & Pollak, M. R. (2010). Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science, 329(5993), 841–845.PubMedCrossRef Genovese, G., Friedman, D. J., Ross, M. D., Lecordier, L., Uzureau, P., Freedman, B. I., Bowden, D. W., Langefeld, C. D., Oleksyk, T. K., Uscinski Knob, A. L., Bernhardy, A. J., Hicks, P. J., Nelson, G. W., Vanhollebeke, B., Winkler, C. A., Kopp, J. B., Pays, E., & Pollak, M. R. (2010). Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science, 329(5993), 841–845.PubMedCrossRef

go back to reference Lusis, A. J. (2012). Life after GWAS. Atertio Thromb Vasc Biol, 32(2), 169–169.CrossRef Lusis, A. J. (2012). Life after GWAS. Atertio Thromb Vasc Biol, 32(2), 169–169.CrossRef

go back to reference Pomerantz, M. M., Ahmadiyeh, N., Jia, L., Herman, P., Verzi, M. P., Doddapaneni, H., Beckwith, C. A., Chan, J. A., Hills, A., Davis, M., Yao, K., Kehoe, S. M., Lenz, H.-J., Haiman, C. A., Yan, C., Henderson, B. E., Frenkel, B., Barretina, J., Bass, A., Tabernero, J., Baselga, J., Regan, M. M., Manak, J. R., Shivdasani, R., Coetzee, G. A., & Freedman, M. L. (2009). The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet, 41(8), 882–884.PubMedCrossRef Pomerantz, M. M., Ahmadiyeh, N., Jia, L., Herman, P., Verzi, M. P., Doddapaneni, H., Beckwith, C. A., Chan, J. A., Hills, A., Davis, M., Yao, K., Kehoe, S. M., Lenz, H.-J., Haiman, C. A., Yan, C., Henderson, B. E., Frenkel, B., Barretina, J., Bass, A., Tabernero, J., Baselga, J., Regan, M. M., Manak, J. R., Shivdasani, R., Coetzee, G. A., & Freedman, M. L. (2009). The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet, 41(8), 882–884.PubMedCrossRef

go back to reference Pearson, E. R. (2009). Pharmacogenetics in diabetes. Curr Diab Rep, 9(2), 172–181.PubMedCrossRef Pearson, E. R. (2009). Pharmacogenetics in diabetes. Curr Diab Rep, 9(2), 172–181.PubMedCrossRef

go back to reference McCarthy, M. I. (2010). Genomics, type 2 diabetes, and obesity. New Engl J Med, 363(24), 2339–2350.PubMedCrossRef McCarthy, M. I. (2010). Genomics, type 2 diabetes, and obesity. New Engl J Med, 363(24), 2339–2350.PubMedCrossRef

go back to reference The Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med, 329(14), 977–986.CrossRef The Diabetes Control and Complications Trial Research Group. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Engl J Med, 329(14), 977–986.CrossRef

go back to reference UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352(9131), 837–853.CrossRef UK Prospective Diabetes Study (UKPDS) Group. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). The Lancet, 352(9131), 837–853.CrossRef

go back to reference Engerman, R. L., & Kern, T. S. (1987). Progression of incipient diabetic retinopathy during good glycemic control. Diabetes, 36(7), 808–812.PubMedCrossRef Engerman, R. L., & Kern, T. S. (1987). Progression of incipient diabetic retinopathy during good glycemic control. Diabetes, 36(7), 808–812.PubMedCrossRef

go back to reference Ihnat, M. A., Thorpe, J. E., & Ceriello, A. (2007). Hypothesis: the ‘metabolic memory’, the new challenge of diabetes. Diabet Med, 24(6), 582–586.PubMedCrossRef Ihnat, M. A., Thorpe, J. E., & Ceriello, A. (2007). Hypothesis: the ‘metabolic memory’, the new challenge of diabetes. Diabet Med, 24(6), 582–586.PubMedCrossRef

go back to reference El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008). Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med, 205(10), 2409–2417.PubMedCrossRef El-Osta, A., Brasacchio, D., Yao, D., Pocai, A., Jones, P. L., Roeder, R. G., Cooper, M. E., & Brownlee, M. (2008). Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J Exp Med, 205(10), 2409–2417.PubMedCrossRef

go back to reference Feinberg, A. P. (2008). Epigenetics at the epicenter of modern medicine. JAMA, 299(11), 1345–1350.PubMedCrossRef Feinberg, A. P. (2008). Epigenetics at the epicenter of modern medicine. JAMA, 299(11), 1345–1350.PubMedCrossRef

go back to reference Ceriello, A., Ihnat, M. A., & Thorpe, J. E. (2009). The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab, 94(2), 410–415.PubMedCrossRef Ceriello, A., Ihnat, M. A., & Thorpe, J. E. (2009). The “metabolic memory”: is more than just tight glucose control necessary to prevent diabetic complications? J Clin Endocrinol Metab, 94(2), 410–415.PubMedCrossRef

go back to reference Dwivedi, R. S., Herman, J. G., McCaffrey, T. A., & Raj, D. S. C. (2011). Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int, 79(1), 23–32.PubMedCrossRef Dwivedi, R. S., Herman, J. G., McCaffrey, T. A., & Raj, D. S. C. (2011). Beyond genetics: epigenetic code in chronic kidney disease. Kidney Int, 79(1), 23–32.PubMedCrossRef

go back to reference Reddy, M. A., & Natarajan, R. (2011). Epigenetics in diabetic kidney disease. J Am Soc Nephrol, 22(12), 2182–2185.PubMedCrossRef Reddy, M. A., & Natarajan, R. (2011). Epigenetics in diabetic kidney disease. J Am Soc Nephrol, 22(12), 2182–2185.PubMedCrossRef

go back to reference Villeneuve, L. M., & Natarajan, R. (2010). Epigenetics of diabetic complications. Expert Rev Endocrinol Metab, 5(1), 137–148. Villeneuve, L. M., & Natarajan, R. (2010). Epigenetics of diabetic complications. Expert Rev Endocrinol Metab, 5(1), 137–148.

go back to reference Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010). Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol, 6(12), 665–675.PubMedCrossRef Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010). Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol, 6(12), 665–675.PubMedCrossRef

go back to reference Mohtat, D., & Susztak, K. (2010). Fine tuning gene expression: the epigenome. Semin Nephrol, 30(5), 468–476.PubMedCrossRef Mohtat, D., & Susztak, K. (2010). Fine tuning gene expression: the epigenome. Semin Nephrol, 30(5), 468–476.PubMedCrossRef

go back to reference Reddy, M. A., & Natarajan, R. (2011). Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res, 90(3), 421–429.PubMedCrossRef Reddy, M. A., & Natarajan, R. (2011). Epigenetic mechanisms in diabetic vascular complications. Cardiovasc Res, 90(3), 421–429.PubMedCrossRef

go back to reference Thomas, M. C., Groop, P.-H., & Tryggvason, K. (2012). Towards understanding the inherited susceptibility for nephropathy in diabetes. Curr Opin Nephrol Hypertens, 21(2), 195–202.PubMedCrossRef Thomas, M. C., Groop, P.-H., & Tryggvason, K. (2012). Towards understanding the inherited susceptibility for nephropathy in diabetes. Curr Opin Nephrol Hypertens, 21(2), 195–202.PubMedCrossRef

go back to reference Wetterstrand, K. (2012) DNA sequencing costs: data from the NHGRI Large-Scale Genome Sequencing Program. Available at: http://wwwgenomegov/sequencingcosts. Accessed March 20, 2012. Wetterstrand, K. (2012) DNA sequencing costs: data from the NHGRI Large-Scale Genome Sequencing Program. Available at: http://​wwwgenomegov/​sequencingcosts. Accessed March 20, 2012.

go back to reference Schena, M., Shalon, D., Davis, R. W., & Brown, P. O. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270(5235), 467–470.PubMedCrossRef Schena, M., Shalon, D., Davis, R. W., & Brown, P. O. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270(5235), 467–470.PubMedCrossRef

go back to reference Kretzler, M., Cohen, C. D., Doran, P., Henger, A., Madden, S., Gröne, E. F., Nelson, P. J., Schlöndorff, D., & Gröne, H.-J. (2002). Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J Am Soc Nephrol, 13(7), 1961–1972.PubMedCrossRef Kretzler, M., Cohen, C. D., Doran, P., Henger, A., Madden, S., Gröne, E. F., Nelson, P. J., Schlöndorff, D., & Gröne, H.-J. (2002). Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology. J Am Soc Nephrol, 13(7), 1961–1972.PubMedCrossRef

go back to reference Cohen, C. D., Frach, K., Schlondorff, D., & Kretzler, M. (2002). Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int, 61(1), 133–140.PubMedCrossRef Cohen, C. D., Frach, K., Schlondorff, D., & Kretzler, M. (2002). Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int, 61(1), 133–140.PubMedCrossRef

go back to reference Schmid, H., Henger, A., Cohen, C. D., Frach, K., Gröne, H.-J., Schlöndorff, D., & Kretzler, M. (2003). Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol, 14(11), 2958–2966.PubMedCrossRef Schmid, H., Henger, A., Cohen, C. D., Frach, K., Gröne, H.-J., Schlöndorff, D., & Kretzler, M. (2003). Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol, 14(11), 2958–2966.PubMedCrossRef

go back to reference Kieran, N. E., Doran, P. P., Connolly, S. B., Greenan, M.-C., Higgins, D. F., Leonard, M., Godson, C., Taylor, C. T., Henger, A., Kretzler, M., Burne, M. J., Rabb, H., & Brady, H. R. (2003). Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int, 64(2), 480–492.PubMedCrossRef Kieran, N. E., Doran, P. P., Connolly, S. B., Greenan, M.-C., Higgins, D. F., Leonard, M., Godson, C., Taylor, C. T., Henger, A., Kretzler, M., Burne, M. J., Rabb, H., & Brady, H. R. (2003). Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int, 64(2), 480–492.PubMedCrossRef

go back to reference Henger, A., Kretzler, M., Doran, P., Bonrouhi, M., Schmid, H., Kiss, E., Cohen, C. D., Madden, S., Porubsky, S., Grone, E. F., Schlondorff, D., Nelson, P. J., & Grone, H.-J. (2004). Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int, 65(3), 904–917.PubMedCrossRef Henger, A., Kretzler, M., Doran, P., Bonrouhi, M., Schmid, H., Kiss, E., Cohen, C. D., Madden, S., Porubsky, S., Grone, E. F., Schlondorff, D., Nelson, P. J., & Grone, H.-J. (2004). Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression. Kidney Int, 65(3), 904–917.PubMedCrossRef

go back to reference Baelde, H. J., Eikmans, M., Doran, P. P., Lappin, D. W. P., de Heer, E., & Bruijn, J. A. (2004). Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis, 43(4), 636–650.PubMedCrossRef Baelde, H. J., Eikmans, M., Doran, P. P., Lappin, D. W. P., de Heer, E., & Bruijn, J. A. (2004). Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis, 43(4), 636–650.PubMedCrossRef

go back to reference Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., Nelson, P. J., Schlöndorff, D., Cohen, C. D., & Kretzler, M. (2006). Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy. Diabetes, 55(11), 2993–3003.PubMedCrossRef Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Gröne, H.-J., Nelson, P. J., Schlöndorff, D., Cohen, C. D., & Kretzler, M. (2006). Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy. Diabetes, 55(11), 2993–3003.PubMedCrossRef

go back to reference Lindenmeyer, M. T., Kretzler, M., Boucherot, A., Berra, S., Yasuda, Y., Henger, A., Eichinger, F., Gaiser, S., Schmid, H., Rastaldi, M. P., Schrier, R. W., Schlondorff, D., & Cohen, C. D. (2007). Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol, 18(6), 1765–1776.PubMedCrossRef Lindenmeyer, M. T., Kretzler, M., Boucherot, A., Berra, S., Yasuda, Y., Henger, A., Eichinger, F., Gaiser, S., Schmid, H., Rastaldi, M. P., Schrier, R. W., Schlondorff, D., & Cohen, C. D. (2007). Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. J Am Soc Nephrol, 18(6), 1765–1776.PubMedCrossRef

go back to reference Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011). Transcriptome analysis of human diabetic kidney disease. Diabetes, 60(9), 2354–2369.PubMedCrossRef Woroniecka, K. I., Park, A. S. D., Mohtat, D., Thomas, D. B., Pullman, J. M., & Susztak, K. (2011). Transcriptome analysis of human diabetic kidney disease. Diabetes, 60(9), 2354–2369.PubMedCrossRef

go back to reference Lin, Y. L., Peng, S. J., Ferng, S. H., Tzen, C. Y., & Yang, C. S. (2009). Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease. Int J Clin Pract, 63(8), 1167–1176.PubMedCrossRef Lin, Y. L., Peng, S. J., Ferng, S. H., Tzen, C. Y., & Yang, C. S. (2009). Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease. Int J Clin Pract, 63(8), 1167–1176.PubMedCrossRef

go back to reference Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984). Structural-functional relationships in diabetic nephropathy. J Clin Invest, 74(4), 1143–1155.PubMedCrossRef Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984). Structural-functional relationships in diabetic nephropathy. J Clin Invest, 74(4), 1143–1155.PubMedCrossRef

go back to reference Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997). Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest, 99(2), 342–348.PubMedCrossRef Pagtalunan, M. E., Miller, P. L., Jumping-Eagle, S., Nelson, R. G., Myers, B. D., Rennke, H. G., Coplon, N. S., Sun, L., & Meyer, T. W. (1997). Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest, 99(2), 342–348.PubMedCrossRef

go back to reference Moutzouris, D.-A., Herlitz, L., Appel, G. B., Markowitz, G. S., Freudenthal, B., Radhakrishnan, J., & D’Agati, V. D. (2009). Renal biopsy in the very elderly. Clin J Am Soc Nephrol, 4(6), 1073–1082.PubMedCrossRef Moutzouris, D.-A., Herlitz, L., Appel, G. B., Markowitz, G. S., Freudenthal, B., Radhakrishnan, J., & D’Agati, V. D. (2009). Renal biopsy in the very elderly. Clin J Am Soc Nephrol, 4(6), 1073–1082.PubMedCrossRef

go back to reference Zhang, P.-P., Ge, Y.-C., Li, S.-J., Xie, H.-L., Li, L.-S., & Liu, Z.-H. (2011). Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients. Nephrology, 16(1), 100–105.PubMedCrossRef Zhang, P.-P., Ge, Y.-C., Li, S.-J., Xie, H.-L., Li, L.-S., & Liu, Z.-H. (2011). Renal biopsy in type 2 diabetes: timing of complications and evaluating of safety in Chinese patients. Nephrology, 16(1), 100–105.PubMedCrossRef

go back to reference Cohen, C. D., Grone, H.-J., Grone, E. F., Nelson, P. J., Schlondorff, D., & Kretzler, M. (2002). Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int, 61(1), 125–132.PubMedCrossRef Cohen, C. D., Grone, H.-J., Grone, E. F., Nelson, P. J., Schlondorff, D., & Kretzler, M. (2002). Laser microdissection and gene expression analysis on formaldehyde-fixed archival tissue. Kidney Int, 61(1), 125–132.PubMedCrossRef

go back to reference Hodgin, J. B., Borczuk, A. C., Nasr, S. H., Markowitz, G. S., Nair, V., Martini, S., Eichinger, F., Vining, C., Berthier, C. C., Kretzler, M., & D’Agati, V. D. (2010). A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol, 177(4), 1674–1686.PubMedCrossRef Hodgin, J. B., Borczuk, A. C., Nasr, S. H., Markowitz, G. S., Nair, V., Martini, S., Eichinger, F., Vining, C., Berthier, C. C., Kretzler, M., & D’Agati, V. D. (2010). A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue. Am J Pathol, 177(4), 1674–1686.PubMedCrossRef

go back to reference Shen-Orr, S. S., Tibshirani, R., Khatri, P., Bodian, D. L., Staedtler, F., Perry, N. M., Hastie, T., Sarwal, M. M., Davis, M. M., & Butte, A. J. (2010). Cell type-specific gene expression differences in complex tissues. Nat Methods, 7(4), 287–289.PubMedCrossRef Shen-Orr, S. S., Tibshirani, R., Khatri, P., Bodian, D. L., Staedtler, F., Perry, N. M., Hastie, T., Sarwal, M. M., Davis, M. M., & Butte, A. J. (2010). Cell type-specific gene expression differences in complex tissues. Nat Methods, 7(4), 287–289.PubMedCrossRef

go back to reference Kaiser, J. (2012). Biomarker tests need closer scrutiny, IOM concludes. Science, 335(6076), 1554–1554.PubMedCrossRef Kaiser, J. (2012). Biomarker tests need closer scrutiny, IOM concludes. Science, 335(6076), 1554–1554.PubMedCrossRef

go back to reference Consensus Report Institute of Medicine (2012) Evolution of translational OMICS: lessons learned and the path forward. At: http://wwwiomedu/Reports/2012/Evolution-of-Translational-Omics.aspx. Accessed March 23, 2012 Consensus Report Institute of Medicine (2012) Evolution of translational OMICS: lessons learned and the path forward. At: http://​wwwiomedu/​Reports/​2012/​Evolution-of-Translational-Omics.​aspx. Accessed March 23, 2012

go back to reference Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. (1999). Correlation between protein and mRNA abundance in yeast. Mol Cell Biol, 19(3), 1720–1730.PubMed Gygi, S. P., Rochon, Y., Franza, B. R., & Aebersold, R. (1999). Correlation between protein and mRNA abundance in yeast. Mol Cell Biol, 19(3), 1720–1730.PubMed

go back to reference Cravatt, B. F., Simon, G. M., & Yates Iii, J. R. (2007). The biological impact of mass-spectrometry-based proteomics. Nature, 450(7172), 991–1000.PubMedCrossRef Cravatt, B. F., Simon, G. M., & Yates Iii, J. R. (2007). The biological impact of mass-spectrometry-based proteomics. Nature, 450(7172), 991–1000.PubMedCrossRef

go back to reference Vogel, C., & Marcotte, E. M. (2012). Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet, 13(4), 227–232.PubMed Vogel, C., & Marcotte, E. M. (2012). Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet, 13(4), 227–232.PubMed

go back to reference Sébédio, J.-L., Pujos-Guillot, E., & Ferrara, M. (2009). Metabolomics in evaluation of glucose disorders. Curr Opin Clin Nutr Metab Care, 12(4), 412–418.PubMedCrossRef Sébédio, J.-L., Pujos-Guillot, E., & Ferrara, M. (2009). Metabolomics in evaluation of glucose disorders. Curr Opin Clin Nutr Metab Care, 12(4), 412–418.PubMedCrossRef

go back to reference Wang, J. H., Byun, J., & Pennathur, S. (2010). Analytical approaches to metabolomics and applications to systems biology. Semin Nephrol, 30(5), 500–511.PubMedCrossRef Wang, J. H., Byun, J., & Pennathur, S. (2010). Analytical approaches to metabolomics and applications to systems biology. Semin Nephrol, 30(5), 500–511.PubMedCrossRef

go back to reference Ben Ameur, R., Molina, L., Bolvin, C., Kifagi, C., Jarraya, F., Ayadi, H., Molina, F., & Granier, C. (2010). Proteomic approaches for discovering biomarkers of diabetic nephropathy. Nephrol Dial Transplant, 25(9), 2866–2875.PubMedCrossRef Ben Ameur, R., Molina, L., Bolvin, C., Kifagi, C., Jarraya, F., Ayadi, H., Molina, F., & Granier, C. (2010). Proteomic approaches for discovering biomarkers of diabetic nephropathy. Nephrol Dial Transplant, 25(9), 2866–2875.PubMedCrossRef

go back to reference Thongboonkerd, V. (2011). Study of diabetic nephropathy in the proteomic era. Contrib Nephrol, 170, 172–183.PubMedCrossRef Thongboonkerd, V. (2011). Study of diabetic nephropathy in the proteomic era. Contrib Nephrol, 170, 172–183.PubMedCrossRef

go back to reference Mäkinen, V.-P., Tynkkynen, T., Soininen, P., Peltola, T., Kangas, A. J., Forsblom, C., Thorn, L. M., Kaski, K., Laatikainen, R., Ala-Korpela, M., & Groop, P.-H. (2012). Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). J Proteome Res, 11(3), 1782–1790.PubMedCrossRef Mäkinen, V.-P., Tynkkynen, T., Soininen, P., Peltola, T., Kangas, A. J., Forsblom, C., Thorn, L. M., Kaski, K., Laatikainen, R., Ala-Korpela, M., & Groop, P.-H. (2012). Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). J Proteome Res, 11(3), 1782–1790.PubMedCrossRef

go back to reference Thongboonkerd, V., & Malasit, P. (2005). Renal and urinary proteomics: current applications and challenges. Proteomics, 5(4), 1033–1042.PubMedCrossRef Thongboonkerd, V., & Malasit, P. (2005). Renal and urinary proteomics: current applications and challenges. Proteomics, 5(4), 1033–1042.PubMedCrossRef

go back to reference Decramer, S., de Peredo, A. G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J.-L., & Schanstra, J. P. (2008). Urine in clinical proteomics. Mol Cell Proteomics, 7(10), 1850–1862.PubMedCrossRef Decramer, S., de Peredo, A. G., Breuil, B., Mischak, H., Monsarrat, B., Bascands, J.-L., & Schanstra, J. P. (2008). Urine in clinical proteomics. Mol Cell Proteomics, 7(10), 1850–1862.PubMedCrossRef

go back to reference Rossing, K., Mischak, H., Dakna, M., Zurbig, P., Novak, J., Julian, B. A., Good, D. M., Coon, J. J., Tarnow, L., Rossing, P., & on behalf of the PREDICTIONS Network. (2008). Urinary proteomics in diabetes and CKD. J Am Soc Nephrol, 19(7), 1283–1290.PubMedCrossRef Rossing, K., Mischak, H., Dakna, M., Zurbig, P., Novak, J., Julian, B. A., Good, D. M., Coon, J. J., Tarnow, L., Rossing, P., & on behalf of the PREDICTIONS Network. (2008). Urinary proteomics in diabetes and CKD. J Am Soc Nephrol, 19(7), 1283–1290.PubMedCrossRef

go back to reference Merchant, M. L., Perkins, B. A., Boratyn, G. M., Ficociello, L. H., Wilkey, D. W., Barati, M. T., Bertram, C. C., Page, G. P., Rovin, B. H., Warram, J. H., Krolewski, A. S., & Klein, J. B. (2009). Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol, 20(9), 2065–2074.PubMedCrossRef Merchant, M. L., Perkins, B. A., Boratyn, G. M., Ficociello, L. H., Wilkey, D. W., Barati, M. T., Bertram, C. C., Page, G. P., Rovin, B. H., Warram, J. H., Krolewski, A. S., & Klein, J. B. (2009). Urinary peptidome may predict renal function decline in type 1 diabetes and microalbuminuria. J Am Soc Nephrol, 20(9), 2065–2074.PubMedCrossRef

go back to reference Otu, H. H., Can, H., Spentzos, D., Nelson, R. G., Hanson, R. L., Looker, H. C., Knowler, W. C., Monroy, M., Libermann, T. A., Karumanchi, S. A., & Thadhani, R. (2007). Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care, 30(3), 638–643.PubMedCrossRef Otu, H. H., Can, H., Spentzos, D., Nelson, R. G., Hanson, R. L., Looker, H. C., Knowler, W. C., Monroy, M., Libermann, T. A., Karumanchi, S. A., & Thadhani, R. (2007). Prediction of diabetic nephropathy using urine proteomic profiling 10 years prior to development of nephropathy. Diabetes Care, 30(3), 638–643.PubMedCrossRef

go back to reference Overgaard, A., Hansen, H., Lajer, M., Pedersen, L., Tarnow, L., Rossing, P., McGuire, J., & Pociot, F. (2010). Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy. Proteome Sci, 8(1), 4.PubMedCrossRef Overgaard, A., Hansen, H., Lajer, M., Pedersen, L., Tarnow, L., Rossing, P., McGuire, J., & Pociot, F. (2010). Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy. Proteome Sci, 8(1), 4.PubMedCrossRef

go back to reference Overgaard, A. J., Thingholm, T. E., Larsen, M. R., Tarnow, L., Rossing, P., McGuire, J. N., & Pociot, F. (2010). Quantitative iTRAQ-based proteomic identification of candidate biomarkers for diabetic nephropathy in plasma of type 1 diabetic patients. Clin Proteomics, 6(4), 105–114.PubMedCrossRef Overgaard, A. J., Thingholm, T. E., Larsen, M. R., Tarnow, L., Rossing, P., McGuire, J. N., & Pociot, F. (2010). Quantitative iTRAQ-based proteomic identification of candidate biomarkers for diabetic nephropathy in plasma of type 1 diabetic patients. Clin Proteomics, 6(4), 105–114.PubMedCrossRef

go back to reference Coon, J. J., Zürbig, P., Dakna, M., Dominiczak, A. F., Decramer, S., Fliser, D., Frommberger, M., Golovko, I., Good, D. M., Herget-Rosenthal, S., Jankowski, J., Julian, B. A., Kellmann, M., Kolch, W., Massy, Z., Novak, J., Rossing, K., Schanstra, J. P., Schiffer, E., Theodorescu, D., Vanholder, R., Weissinger, E. M., Mischak, H., & Schmitt-Kopplin, P. (2008). CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl, 2(7–8), 964–973.PubMedCrossRef Coon, J. J., Zürbig, P., Dakna, M., Dominiczak, A. F., Decramer, S., Fliser, D., Frommberger, M., Golovko, I., Good, D. M., Herget-Rosenthal, S., Jankowski, J., Julian, B. A., Kellmann, M., Kolch, W., Massy, Z., Novak, J., Rossing, K., Schanstra, J. P., Schiffer, E., Theodorescu, D., Vanholder, R., Weissinger, E. M., Mischak, H., & Schmitt-Kopplin, P. (2008). CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl, 2(7–8), 964–973.PubMedCrossRef

go back to reference Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., & Metzger, J. (2009). Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res, 8(1), 268–281.PubMedCrossRef Jantos-Siwy, J., Schiffer, E., Brand, K., Schumann, G., Rossing, K., Delles, C., Mischak, H., & Metzger, J. (2009). Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res, 8(1), 268–281.PubMedCrossRef

go back to reference Maahs, D. M., Siwy, J., Argilés, À., Cerna, M., Delles, C., Dominiczak, A. F., Gayrard, N., Iphöfer, A., Jänsch, L., Jerums, G., Medek, K., Mischak, H., Navis, G. J., Roob, J. M., Rossing, K., Rossing, P., Rychlík, I., Schiffer, E., Schmieder, R. E., Wascher, T. C., Winklhofer-Roob, B. M., Zimmerli, L. U., Zürbig, P., & Snell-Bergeon, J. K. (2010). Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology. PLoS ONE, 5(9), e13051.PubMedCrossRef Maahs, D. M., Siwy, J., Argilés, À., Cerna, M., Delles, C., Dominiczak, A. F., Gayrard, N., Iphöfer, A., Jänsch, L., Jerums, G., Medek, K., Mischak, H., Navis, G. J., Roob, J. M., Rossing, K., Rossing, P., Rychlík, I., Schiffer, E., Schmieder, R. E., Wascher, T. C., Winklhofer-Roob, B. M., Zimmerli, L. U., Zürbig, P., & Snell-Bergeon, J. K. (2010). Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology. PLoS ONE, 5(9), e13051.PubMedCrossRef

go back to reference Alkhalaf, A., Zürbig, P., Bakker, S. J. L., Bilo, H. J. G., Cerna, M., Fischer, C., Fuchs, S., Janssen, B., Medek, K., Mischak, H., Roob, J. M., Rossing, K., Rossing, P., Rychlík, I., Sourij, H., Tiran, B., Winklhofer-Roob, B. M., Navis, G. J., & for the PREDICTIONS Group. (2010). Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS ONE, 5(10), e13421.PubMedCrossRef Alkhalaf, A., Zürbig, P., Bakker, S. J. L., Bilo, H. J. G., Cerna, M., Fischer, C., Fuchs, S., Janssen, B., Medek, K., Mischak, H., Roob, J. M., Rossing, K., Rossing, P., Rychlík, I., Sourij, H., Tiran, B., Winklhofer-Roob, B. M., Navis, G. J., & for the PREDICTIONS Group. (2010). Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS ONE, 5(10), e13421.PubMedCrossRef

go back to reference Good, D. M., Zurbig, P., Argiles, A., Bauer, H. W., Behrens, G., Coon, J. J., Dakna, M., Decramer, S., Delles, C., Dominiczak, A. F., Ehrich, J. H. H., Eitner, F., Fliser, D., Frommberger, M., Ganser, A., Girolami, M. A., Golovko, I., Gwinner, W., Haubitz, M., Herget-Rosenthal, S., Jankowski, J., Jahn, H., Jerums, G., Julian, B. A., Kellmann, M., Kliem, V., Kolch, W., Krolewski, A. S., Luppi, M., Massy, Z., Melter, M., Neususs, C., Novak, J., Peter, K., Rossing, K., Rupprecht, H., Schanstra, J. P., Schiffer, E., Stolzenburg, J.-U., Tarnow, L., Theodorescu, D., Thongboonkerd, V., Vanholder, R., Weissinger, E. M., Mischak, H., & Schmitt-Kopplin, P. (2010). Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics, 9(11), 2424–2437.PubMedCrossRef Good, D. M., Zurbig, P., Argiles, A., Bauer, H. W., Behrens, G., Coon, J. J., Dakna, M., Decramer, S., Delles, C., Dominiczak, A. F., Ehrich, J. H. H., Eitner, F., Fliser, D., Frommberger, M., Ganser, A., Girolami, M. A., Golovko, I., Gwinner, W., Haubitz, M., Herget-Rosenthal, S., Jankowski, J., Jahn, H., Jerums, G., Julian, B. A., Kellmann, M., Kliem, V., Kolch, W., Krolewski, A. S., Luppi, M., Massy, Z., Melter, M., Neususs, C., Novak, J., Peter, K., Rossing, K., Rupprecht, H., Schanstra, J. P., Schiffer, E., Stolzenburg, J.-U., Tarnow, L., Theodorescu, D., Thongboonkerd, V., Vanholder, R., Weissinger, E. M., Mischak, H., & Schmitt-Kopplin, P. (2010). Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics, 9(11), 2424–2437.PubMedCrossRef

go back to reference Jain, S., Rajput, A., Kumar, Y., Uppuluri, N., Arvind, A. S., & Tatu, U. (2005). Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Physicians India, 53(June), 513–520.PubMed Jain, S., Rajput, A., Kumar, Y., Uppuluri, N., Arvind, A. S., & Tatu, U. (2005). Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. J Assoc Physicians India, 53(June), 513–520.PubMed

go back to reference Fisher, W. G., Lucas, J. E., Mehdi, U. F., Qunibi, D. W., Garner, H. R., Rosenblatt, K. P., & Toto, R. D. (2011). A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy. Proteomics Clin Appl, 5(11–12), 603–612.PubMedCrossRef Fisher, W. G., Lucas, J. E., Mehdi, U. F., Qunibi, D. W., Garner, H. R., Rosenblatt, K. P., & Toto, R. D. (2011). A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy. Proteomics Clin Appl, 5(11–12), 603–612.PubMedCrossRef

go back to reference Lowe, J. B. (2001). Glycosylation, immunity, and autoimmunity. Cell, 104(6), 809–812.PubMedCrossRef Lowe, J. B. (2001). Glycosylation, immunity, and autoimmunity. Cell, 104(6), 809–812.PubMedCrossRef

go back to reference Yang, N., Feng, S., Shedden, K., Xie, X., Liu, Y., Rosser, C. J., Lubman, D. M., & Goodison, S. (2011). Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification. Clin Cancer Res, 17(10), 3349–3359.PubMedCrossRef Yang, N., Feng, S., Shedden, K., Xie, X., Liu, Y., Rosser, C. J., Lubman, D. M., & Goodison, S. (2011). Urinary glycoprotein biomarker discovery for bladder cancer detection using LC/MS-MS and label-free quantification. Clin Cancer Res, 17(10), 3349–3359.PubMedCrossRef

go back to reference Ahn, J.-M., Kim, B.-G., Yu, M.-H., Lee, I.-K., & Cho, J.-Y. (2010). Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS/MS. Proteomics Clin Appl, 4(6–7), 644–653.PubMedCrossRef Ahn, J.-M., Kim, B.-G., Yu, M.-H., Lee, I.-K., & Cho, J.-Y. (2010). Identification of diabetic nephropathy-selective proteins in human plasma by multi-lectin affinity chromatography and LC-MS/MS. Proteomics Clin Appl, 4(6–7), 644–653.PubMedCrossRef

go back to reference Vivekanandan-Giri, A., Slocum, J. L., Buller, C. L., Basrur, V., Ju, W., Pop-Busui, R., et al. (2011). Urine glycoprotein profile reveals novel markers for chronic kidney disease. Int J Proteomics, 2011, 18. Article ID 214715. Vivekanandan-Giri, A., Slocum, J. L., Buller, C. L., Basrur, V., Ju, W., Pop-Busui, R., et al. (2011). Urine glycoprotein profile reveals novel markers for chronic kidney disease. Int J Proteomics, 2011, 18. Article ID 214715.

go back to reference Pisitkun, T., Shen, R.-F., & Knepper, M. A. (2004). Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA, 101(36), 13368–13373.PubMedCrossRef Pisitkun, T., Shen, R.-F., & Knepper, M. A. (2004). Identification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA, 101(36), 13368–13373.PubMedCrossRef

go back to reference Gonzales, P. A., Pisitkun, T., Hoffert, J. D., Tchapyjnikov, D., Star, R. A., Kleta, R., Wang, N. S., & Knepper, M. A. (2009). Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol, 20(2), 363–379.PubMedCrossRef Gonzales, P. A., Pisitkun, T., Hoffert, J. D., Tchapyjnikov, D., Star, R. A., Kleta, R., Wang, N. S., & Knepper, M. A. (2009). Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol, 20(2), 363–379.PubMedCrossRef

go back to reference Konvalinka, A., Scholey, J. W., & Diamandis, E. P. (2012). Searching for new biomarkers of renal diseases through proteomics. Clin Chem, 58(2), 353–365.PubMedCrossRef Konvalinka, A., Scholey, J. W., & Diamandis, E. P. (2012). Searching for new biomarkers of renal diseases through proteomics. Clin Chem, 58(2), 353–365.PubMedCrossRef

go back to reference Mischak, H., Apweiler, R., Banks, R. E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J. H. H., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D., Jankowski, J., Julian, B. A., Kolch, W., Massy, Z. A., Neusuess, C., Novak, J., Peter, K., Rossing, K., Schanstra, J., Semmes, O. J., Theodorescu, D., Thongboonkerd, V., Weissinger, E. M., Van Eyk, J. E., & Yamamoto, T. (2007). Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl, 1(2), 148–156.PubMedCrossRef Mischak, H., Apweiler, R., Banks, R. E., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J. H. H., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D., Jankowski, J., Julian, B. A., Kolch, W., Massy, Z. A., Neusuess, C., Novak, J., Peter, K., Rossing, K., Schanstra, J., Semmes, O. J., Theodorescu, D., Thongboonkerd, V., Weissinger, E. M., Van Eyk, J. E., & Yamamoto, T. (2007). Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl, 1(2), 148–156.PubMedCrossRef

go back to reference Good, D. M., Thongboonkerd, V., Novak, J., Bascands, J.-L., Schanstra, J. P., Coon, J. J., Dominiczak, A., & Mischak, H. (2007). Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res, 6(12), 4549–4555.PubMedCrossRef Good, D. M., Thongboonkerd, V., Novak, J., Bascands, J.-L., Schanstra, J. P., Coon, J. J., Dominiczak, A., & Mischak, H. (2007). Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res, 6(12), 4549–4555.PubMedCrossRef

go back to reference Kinsinger, C. R., Apffel, J., Baker, M., Bian, X., Borchers, C. H., Bradshaw, R., Brusniak, M.-Y., Chan, D. W., Deutsch, E. W., Domon, B., Gorman, J., Grimm, R., Hancock, W., Hermjakob, H., Horn, D., Hunter, C., Kolar, P., Kraus, H.-J., Langen, H., Linding, R., Moritz, R. L., Omenn, G. S., Orlando, R., Pandey, A., Ping, P., Rahbar, A., Rivers, R., Seymour, S. L., Simpson, R. J., Slotta, D., Smith, R. D., Stein, S. E., Tabb, D. L., Tagle, D., Yates, J. R., & Rodriguez, H. (2011). Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles). Proteomics Clin Appl, 5(11–12), 580–589.PubMedCrossRef Kinsinger, C. R., Apffel, J., Baker, M., Bian, X., Borchers, C. H., Bradshaw, R., Brusniak, M.-Y., Chan, D. W., Deutsch, E. W., Domon, B., Gorman, J., Grimm, R., Hancock, W., Hermjakob, H., Horn, D., Hunter, C., Kolar, P., Kraus, H.-J., Langen, H., Linding, R., Moritz, R. L., Omenn, G. S., Orlando, R., Pandey, A., Ping, P., Rahbar, A., Rivers, R., Seymour, S. L., Simpson, R. J., Slotta, D., Smith, R. D., Stein, S. E., Tabb, D. L., Tagle, D., Yates, J. R., & Rodriguez, H. (2011). Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles). Proteomics Clin Appl, 5(11–12), 580–589.PubMedCrossRef

go back to reference Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., Gaasterland, T., Glenisson, P., Holstege, F. C. P., Kim, I. F., Markowitz, V., Matese, J. C., Parkinson, H., Robinson, A., Sarkans, U., Schulze-Kremer, S., Stewart, J., Taylor, R., Vilo, J., & Vingron, M. (2001). Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nat Genet, 29(4), 365–371.PubMedCrossRef Brazma, A., Hingamp, P., Quackenbush, J., Sherlock, G., Spellman, P., Stoeckert, C., Aach, J., Ansorge, W., Ball, C. A., Causton, H. C., Gaasterland, T., Glenisson, P., Holstege, F. C. P., Kim, I. F., Markowitz, V., Matese, J. C., Parkinson, H., Robinson, A., Sarkans, U., Schulze-Kremer, S., Stewart, J., Taylor, R., Vilo, J., & Vingron, M. (2001). Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nat Genet, 29(4), 365–371.PubMedCrossRef

go back to reference Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C., & Chinnaiyan, A. M. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457(7231), 910–914.PubMedCrossRef Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., Nyati, M. K., Ahsan, A., Kalyana-Sundaram, S., Han, B., Cao, X., Byun, J., Omenn, G. S., Ghosh, D., Pennathur, S., Alexander, D. C., Berger, A., Shuster, J. R., Wei, J. T., Varambally, S., Beecher, C., & Chinnaiyan, A. M. (2009). Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature, 457(7231), 910–914.PubMedCrossRef

go back to reference Kim, K., Aronov, P., Zakharkin, S. O., Anderson, D., Perroud, B., Thompson, I. M., & Weiss, R. H. (2009). Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics, 8(3), 558–570.PubMedCrossRef Kim, K., Aronov, P., Zakharkin, S. O., Anderson, D., Perroud, B., Thompson, I. M., & Weiss, R. H. (2009). Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol Cell Proteomics, 8(3), 558–570.PubMedCrossRef

go back to reference Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., Rochon, J., Gallup, D., Ilkayeva, O., Wenner, B. R., Yancy, W. S., Jr., Eisenson, H., Musante, G., Surwit, R. S., Millington, D. S., Butler, M. D., & Svetkey, L. P. (2009). A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism, 9(4), 311–326.PubMedCrossRef Newgard, C. B., An, J., Bain, J. R., Muehlbauer, M. J., Stevens, R. D., Lien, L. F., Haqq, A. M., Shah, S. H., Arlotto, M., Slentz, C. A., Rochon, J., Gallup, D., Ilkayeva, O., Wenner, B. R., Yancy, W. S., Jr., Eisenson, H., Musante, G., Surwit, R. S., Millington, D. S., Butler, M. D., & Svetkey, L. P. (2009). A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism, 9(4), 311–326.PubMedCrossRef

go back to reference Suhre, K., Meisinger, C., Döring, A., Altmaier, E., Belcredi, P., Gieger, C., Chang, D., Milburn, M. V., Gall, W. E., Weinberger, K. M., Mewes, H.-W., Hrabé de Angelis, M., Wichmann, H. E., Kronenberg, F., Adamski, J., & Illig, T. (2010). Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE, 5(11), e13953.PubMedCrossRef Suhre, K., Meisinger, C., Döring, A., Altmaier, E., Belcredi, P., Gieger, C., Chang, D., Milburn, M. V., Gall, W. E., Weinberger, K. M., Mewes, H.-W., Hrabé de Angelis, M., Wichmann, H. E., Kronenberg, F., Adamski, J., & Illig, T. (2010). Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE, 5(11), e13953.PubMedCrossRef

go back to reference Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., O’Donnell, C. J., Carr, S. A., Mootha, V. K., Florez, J. C., Souza, A., Melander, O., Clish, C. B., & Gerszten, R. E. (2011). Metabolite profiles and the risk of developing diabetes. Nat Med, 17(4), 448–453.PubMedCrossRef Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., O’Donnell, C. J., Carr, S. A., Mootha, V. K., Florez, J. C., Souza, A., Melander, O., Clish, C. B., & Gerszten, R. E. (2011). Metabolite profiles and the risk of developing diabetes. Nat Med, 17(4), 448–453.PubMedCrossRef

go back to reference Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., Carr, S. A., Vasan, R. S., Florez, J. C., Clish, C. B., Wang, T. J., & Gerszten, R. E. (2011). Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest, 121(4), 1402–1411.PubMedCrossRef Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., Carr, S. A., Vasan, R. S., Florez, J. C., Clish, C. B., Wang, T. J., & Gerszten, R. E. (2011). Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest, 121(4), 1402–1411.PubMedCrossRef

go back to reference Ganti, S., & Weiss, R. H. (2011). Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol, 29(5), 551–557.PubMedCrossRef Ganti, S., & Weiss, R. H. (2011). Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol, 29(5), 551–557.PubMedCrossRef

go back to reference Rhee, E. P., & Gerszten, R. E. (2012). Metabolomics and cardiovascular biomarker discovery. Clin Chem, 58(1), 139–147.PubMedCrossRef Rhee, E. P., & Gerszten, R. E. (2012). Metabolomics and cardiovascular biomarker discovery. Clin Chem, 58(1), 139–147.PubMedCrossRef

go back to reference Weiss, R. H., & Kim, K. (2012). Metabolomics in the study of kidney diseases. Nat Rev Nephrol, 8(1), 22–33.CrossRef Weiss, R. H., & Kim, K. (2012). Metabolomics in the study of kidney diseases. Nat Rev Nephrol, 8(1), 22–33.CrossRef

go back to reference Zhang, H., Saha, J., Byun, J., Schin, M., Lorenz, M., Kennedy, R. T., Kretzler, M., Feldman, E. L., Pennathur, S., & Brosius, F. C. (2008). Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol, 295(4), F1071–F1081.PubMedCrossRef Zhang, H., Saha, J., Byun, J., Schin, M., Lorenz, M., Kennedy, R. T., Kretzler, M., Feldman, E. L., Pennathur, S., & Brosius, F. C. (2008). Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol, 295(4), F1071–F1081.PubMedCrossRef

go back to reference Smith, C. A., Maille, G. O., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., Custodio, D. E., Abagyan, R., & Siuzdak, G. (2005). METLIN: a metabolite mass spectral database. Ther Drug Monit, 27(6), 747–751.PubMedCrossRef Smith, C. A., Maille, G. O., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., Custodio, D. E., Abagyan, R., & Siuzdak, G. (2005). METLIN: a metabolite mass spectral database. Ther Drug Monit, 27(6), 747–751.PubMedCrossRef

go back to reference Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., Fung, C., Nikolai, L., Lewis, M., Coutouly, M.-A., Forsythe, I., Tang, P., Shrivastava, S., Jeroncic, K., Stothard, P., Amegbey, G., Block, D., Hau, D. D., Wagner, J., Miniaci, J., Clements, M., Gebremedhin, M., Guo, N., Zhang, Y., Duggan, G. E., MacInnis, G. D., Weljie, A. M., Dowlatabadi, R., Bamforth, F., Clive, D., Greiner, R., Li, L., Marrie, T., Sykes, B. D., Vogel, H. J., & Querengesser, L. (2007). HMDB: the Human Metabolome Database. NAR, 35(suppl 1), D521–D526.PubMedCrossRef Wishart, D. S., Tzur, D., Knox, C., Eisner, R., Guo, A. C., Young, N., Cheng, D., Jewell, K., Arndt, D., Sawhney, S., Fung, C., Nikolai, L., Lewis, M., Coutouly, M.-A., Forsythe, I., Tang, P., Shrivastava, S., Jeroncic, K., Stothard, P., Amegbey, G., Block, D., Hau, D. D., Wagner, J., Miniaci, J., Clements, M., Gebremedhin, M., Guo, N., Zhang, Y., Duggan, G. E., MacInnis, G. D., Weljie, A. M., Dowlatabadi, R., Bamforth, F., Clive, D., Greiner, R., Li, L., Marrie, T., Sykes, B. D., Vogel, H. J., & Querengesser, L. (2007). HMDB: the Human Metabolome Database. NAR, 35(suppl 1), D521–D526.PubMedCrossRef

go back to reference Barreto, F. C., Barreto, D. V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., Massy, Z. A., & on behalf of the European Uremic Toxin Work Group. (2009). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol, 4(10), 1551–1558.PubMedCrossRef Barreto, F. C., Barreto, D. V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R., Massy, Z. A., & on behalf of the European Uremic Toxin Work Group. (2009). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients. Clin J Am Soc Nephrol, 4(10), 1551–1558.PubMedCrossRef

go back to reference Zhang, J., Yan, L., Chen, W., Lin, L., Song, X., Yan, X., Hang, W., & Huang, B. (2009). Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC–oaTOF-MS system. Anal Chim Acta, 650(1), 16–22.PubMedCrossRef Zhang, J., Yan, L., Chen, W., Lin, L., Song, X., Yan, X., Hang, W., & Huang, B. (2009). Metabonomics research of diabetic nephropathy and type 2 diabetes mellitus based on UPLC–oaTOF-MS system. Anal Chim Acta, 650(1), 16–22.PubMedCrossRef

go back to reference van der Kloet, F., Tempels, F., Ismail, N., van der Heijden, R., Kasper, P., Rojas-Cherto, M., van Doorn, R., Spijksma, G., Koek, M., van der Greef, J., Mäkinen, V., Forsblom, C., Holthöfer, H., Groop, P., Reijmers, T., & Hankemeier, T. (2012). Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics, 8(1), 109–119.PubMedCrossRef van der Kloet, F., Tempels, F., Ismail, N., van der Heijden, R., Kasper, P., Rojas-Cherto, M., van Doorn, R., Spijksma, G., Koek, M., van der Greef, J., Mäkinen, V., Forsblom, C., Holthöfer, H., Groop, P., Reijmers, T., & Hankemeier, T. (2012). Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study). Metabolomics, 8(1), 109–119.PubMedCrossRef

go back to reference Xia, J.-F., Liang, Q.-L., Liang, X.-P., Wang, Y.-M., Hu, P., Li, P., & Luo, G.-A. (2009). Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy. J Chromatogr B Analyt Technol Biomed Life Sci, 877(20–21), 1930–1936.PubMed Xia, J.-F., Liang, Q.-L., Liang, X.-P., Wang, Y.-M., Hu, P., Li, P., & Luo, G.-A. (2009). Ultraviolet and tandem mass spectrometry for simultaneous quantification of 21 pivotal metabolites in plasma from patients with diabetic nephropathy. J Chromatogr B Analyt Technol Biomed Life Sci, 877(20–21), 1930–1936.PubMed

go back to reference Sieberts, S., & Schadt, E. E. (2007). Moving toward a system genetics view of disease. Mamm Genome, 18(6), 389–401.PubMedCrossRef Sieberts, S., & Schadt, E. E. (2007). Moving toward a system genetics view of disease. Mamm Genome, 18(6), 389–401.PubMedCrossRef

go back to reference Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G. B., Gunnarsdottir, S., Mouy, M., Steinthorsdottir, V., Eiriksdottir, G. H., Bjornsdottir, G., Reynisdottir, I., Gudbjartsson, D., Helgadottir, A., Jonasdottir, A., Jonasdottir, A., Styrkarsdottir, U., Gretarsdottir, S., Magnusson, K. P., Stefansson, H., Fossdal, R., Kristjansson, K., Gislason, H. G., Stefansson, T., Leifsson, B. G., Thorsteinsdottir, U., Lamb, J. R., Gulcher, J. R., Reitman, M. L., Kong, A., Schadt, E. E., & Stefansson, K. (2008). Genetics of gene expression and its effect on disease. Nature, 452(7186), 423–428.PubMedCrossRef Emilsson, V., Thorleifsson, G., Zhang, B., Leonardson, A. S., Zink, F., Zhu, J., Carlson, S., Helgason, A., Walters, G. B., Gunnarsdottir, S., Mouy, M., Steinthorsdottir, V., Eiriksdottir, G. H., Bjornsdottir, G., Reynisdottir, I., Gudbjartsson, D., Helgadottir, A., Jonasdottir, A., Jonasdottir, A., Styrkarsdottir, U., Gretarsdottir, S., Magnusson, K. P., Stefansson, H., Fossdal, R., Kristjansson, K., Gislason, H. G., Stefansson, T., Leifsson, B. G., Thorsteinsdottir, U., Lamb, J. R., Gulcher, J. R., Reitman, M. L., Kong, A., Schadt, E. E., & Stefansson, K. (2008). Genetics of gene expression and its effect on disease. Nature, 452(7186), 423–428.PubMedCrossRef

go back to reference Ioannidis, J. P. A., Thomas, G., & Daly, M. J. (2009). Validating, augmenting and refining genome-wide association signals. Nat Rev Genet, 10(5), 318–329.PubMedCrossRef Ioannidis, J. P. A., Thomas, G., & Daly, M. J. (2009). Validating, augmenting and refining genome-wide association signals. Nat Rev Genet, 10(5), 318–329.PubMedCrossRef

go back to reference Keurentjes, J. J. B., Fu, J., de Vos, C. H. R., Lommen, A., Hall, R. D., Bino, R. J., van der Plas, L. H. W., Jansen, R. C., Vreugdenhil, D., & Koornneef, M. (2006). The genetics of plant metabolism. Nat Genet, 38(7), 842–849.PubMedCrossRef Keurentjes, J. J. B., Fu, J., de Vos, C. H. R., Lommen, A., Hall, R. D., Bino, R. J., van der Plas, L. H. W., Jansen, R. C., Vreugdenhil, D., & Koornneef, M. (2006). The genetics of plant metabolism. Nat Genet, 38(7), 842–849.PubMedCrossRef

go back to reference Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.-W., Wichmann, H. E., Weinberger, K. M., Adamski, J., Illig, T., & Suhre, K. (2008). Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet, 4(11), e1000282.PubMedCrossRef Gieger, C., Geistlinger, L., Altmaier, E., Hrabé de Angelis, M., Kronenberg, F., Meitinger, T., Mewes, H.-W., Wichmann, H. E., Weinberger, K. M., Adamski, J., Illig, T., & Suhre, K. (2008). Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum. PLoS Genet, 4(11), e1000282.PubMedCrossRef

go back to reference Ferrara, C. T., Wang, P., Neto, E. C., Stevens, R. D., Bain, J. R., Wenner, B. R., Ilkayeva, O. R., Keller, M. P., Blasiole, D. A., Kendziorski, C., Yandell, B. S., Newgard, C. B., & Attie, A. D. (2008). Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet, 4(3), e1000034.PubMedCrossRef Ferrara, C. T., Wang, P., Neto, E. C., Stevens, R. D., Bain, J. R., Wenner, B. R., Ilkayeva, O. R., Keller, M. P., Blasiole, D. A., Kendziorski, C., Yandell, B. S., Newgard, C. B., & Attie, A. D. (2008). Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet, 4(3), e1000034.PubMedCrossRef

go back to reference Shah, S. H., Hauser, E. R., Bain, J. R., Muehlbauer, M. J., Haynes, C., Stevens, R. D., et al. (2009). High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol, 5, 258.PubMedCrossRef Shah, S. H., Hauser, E. R., Bain, J. R., Muehlbauer, M. J., Haynes, C., Stevens, R. D., et al. (2009). High heritability of metabolomic profiles in families burdened with premature cardiovascular disease. Mol Syst Biol, 5, 258.PubMedCrossRef

go back to reference Suhre, K., Wallaschofski, H., Raffler, J., Friedrich, N., Haring, R., Michael, K., Wasner, C., Krebs, A., Kronenberg, F., Chang, D., Meisinger, C., Wichmann, H. E., Hoffmann, W., Volzke, H., Volker, U., Teumer, A., Biffar, R., Kocher, T., Felix, S. B., Illig, T., Kroemer, H. K., Gieger, C., Romisch-Margl, W., & Nauck, M. (2011). A genome-wide association study of metabolic traits in human urine. Nat Genet, 43(6), 565–569.PubMedCrossRef Suhre, K., Wallaschofski, H., Raffler, J., Friedrich, N., Haring, R., Michael, K., Wasner, C., Krebs, A., Kronenberg, F., Chang, D., Meisinger, C., Wichmann, H. E., Hoffmann, W., Volzke, H., Volker, U., Teumer, A., Biffar, R., Kocher, T., Felix, S. B., Illig, T., Kroemer, H. K., Gieger, C., Romisch-Margl, W., & Nauck, M. (2011). A genome-wide association study of metabolic traits in human urine. Nat Genet, 43(6), 565–569.PubMedCrossRef

go back to reference Daly, A. K. (2010). Drug-induced liver injury: past, present and future. Pharmacogenomics, 11(5), 607–611.PubMedCrossRef Daly, A. K. (2010). Drug-induced liver injury: past, present and future. Pharmacogenomics, 11(5), 607–611.PubMedCrossRef

go back to reference Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., Johansen, C. T., Fouchier, S. W., Isaacs, A., Peloso, G. M., Barbalic, M., Ricketts, S. L., Bis, J. C., Aulchenko, Y. S., Thorleifsson, G., Feitosa, M. F., Chambers, J., Orho-Melander, M., Melander, O., Johnson, T., Li, X., Guo, X., Li, M., Shin Cho, Y., Jin Go, M., Jin Kim, Y., Lee, J.-Y., Park, T., Kim, K., Sim, X., Twee-Hee Ong, R., Croteau-Chonka, D. C., Lange, L. A., Smith, J. D., Song, K., Hua Zhao, J., Yuan, X., Luan, J. A., Lamina, C., Ziegler, A., Zhang, W., Zee, R. Y. L., Wright, A. F., Witteman, J. C. M., Wilson, J. F., Willemsen, G., Wichmann, H. E., Whitfield, J. B., Waterworth, D. M., Wareham, N. J., Waeber, G., Vollenweider, P., Voight, B. F., Vitart, V., Uitterlinden, A. G., Uda, M., Tuomilehto, J., Thompson, J. R., Tanaka, T., Surakka, I., Stringham, H. M., Spector, T. D., Soranzo, N., Smit, J. H., Sinisalo, J., Silander, K., Sijbrands, E. J. G., Scuteri, A., Scott, J., Schlessinger, D., Sanna, S., Salomaa, V., Saharinen, J., Sabatti, C., Ruokonen, A., Rudan, I., Rose, L. M., Roberts, R., Rieder, M., Psaty, B. M., Pramstaller, P. P., Pichler, I., Perola, M., Penninx, B. W. J. H., Pedersen, N. L., Pattaro, C., Parker, A. N., Pare, G., Oostra, B. A., O’Donnell, C. J., Nieminen, M. S., Nickerson, D. A., Montgomery, G. W., Meitinger, T., McPherson, R., McCarthy, M. I., McArdle, W., Masson, D., Martin, N. G., Marroni, F., Mangino, M., Magnusson, P. K. E., Lucas, G., Luben, R., Loos, R. J. F., Lokki, M.-L., Lettre, G., Langenberg, C., Launer, L. J., Lakatta, E. G., Laaksonen, R., Kyvik, K. O., Kronenberg, F., Konig, I. R., Khaw, K.-T., Kaprio, J., Kaplan, L. M., Johansson, A., Jarvelin, M.-R., Cecile, J. W., Janssens, A., Ingelsson, E., Igl, W., Kees Hovingh, G., Hottenga, J.-J., Hofman, A., Hicks, A. A., Hengstenberg, C., Heid, I. M., Hayward, C., Havulinna, A. S., Hastie, N. D., Harris, T. B., Haritunians, T., Hall, A. S., Gyllensten, U., Guiducci, C., Groop, L. C., Gonzalez, E., Gieger, C., Freimer, N. B., Ferrucci, L., Erdmann, J., Elliott, P., Ejebe, K. G., Doring, A., Dominiczak, A. F., Demissie, S., Deloukas, P., de Geus, E. J. C., de Faire, U., Crawford, G., Collins, F. S., Chen, Y.-D. I., Caulfield, M. J., Campbell, H., Burtt, N. P., Bonnycastle, L. L., Boomsma, D. I., Boekholdt, S. M., Bergman, R. N., Barroso, I., Bandinelli, S., Ballantyne, C. M., Assimes, T. L., Quertermous, T., Altshuler, D., Seielstad, M., Wong, T. Y., Tai, E. S., Feranil, A. B., Kuzawa, C. W., Adair, L. S., Taylor, H. A., Jr., Borecki, I. B., Gabriel, S. B., Wilson, J. G., Holm, H., Thorsteinsdottir, U., Gudnason, V., Krauss, R. M., Mohlke, K. L., Ordovas, J. M., Munroe, P. B., Kooner, J. S., Tall, A. R., Hegele, R. A., Kastelein, J. J. P., Schadt, E. E., Rotter, J. I., Boerwinkle, E., Strachan, D. P., Mooser, V., Stefansson, K., Reilly, M. P., Samani, N. J., Schunkert, H., Cupples, L. A., Sandhu, M. S., Ridker, P. M., Rader, D. J., van Duijn, C. M., Peltonen, L., Abecasis, G. R., Boehnke, M., & Kathiresan, S. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466(7307), 707–713.PubMedCrossRef Teslovich, T. M., Musunuru, K., Smith, A. V., Edmondson, A. C., Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Willer, C. J., Johansen, C. T., Fouchier, S. W., Isaacs, A., Peloso, G. M., Barbalic, M., Ricketts, S. L., Bis, J. C., Aulchenko, Y. S., Thorleifsson, G., Feitosa, M. F., Chambers, J., Orho-Melander, M., Melander, O., Johnson, T., Li, X., Guo, X., Li, M., Shin Cho, Y., Jin Go, M., Jin Kim, Y., Lee, J.-Y., Park, T., Kim, K., Sim, X., Twee-Hee Ong, R., Croteau-Chonka, D. C., Lange, L. A., Smith, J. D., Song, K., Hua Zhao, J., Yuan, X., Luan, J. A., Lamina, C., Ziegler, A., Zhang, W., Zee, R. Y. L., Wright, A. F., Witteman, J. C. M., Wilson, J. F., Willemsen, G., Wichmann, H. E., Whitfield, J. B., Waterworth, D. M., Wareham, N. J., Waeber, G., Vollenweider, P., Voight, B. F., Vitart, V., Uitterlinden, A. G., Uda, M., Tuomilehto, J., Thompson, J. R., Tanaka, T., Surakka, I., Stringham, H. M., Spector, T. D., Soranzo, N., Smit, J. H., Sinisalo, J., Silander, K., Sijbrands, E. J. G., Scuteri, A., Scott, J., Schlessinger, D., Sanna, S., Salomaa, V., Saharinen, J., Sabatti, C., Ruokonen, A., Rudan, I., Rose, L. M., Roberts, R., Rieder, M., Psaty, B. M., Pramstaller, P. P., Pichler, I., Perola, M., Penninx, B. W. J. H., Pedersen, N. L., Pattaro, C., Parker, A. N., Pare, G., Oostra, B. A., O’Donnell, C. J., Nieminen, M. S., Nickerson, D. A., Montgomery, G. W., Meitinger, T., McPherson, R., McCarthy, M. I., McArdle, W., Masson, D., Martin, N. G., Marroni, F., Mangino, M., Magnusson, P. K. E., Lucas, G., Luben, R., Loos, R. J. F., Lokki, M.-L., Lettre, G., Langenberg, C., Launer, L. J., Lakatta, E. G., Laaksonen, R., Kyvik, K. O., Kronenberg, F., Konig, I. R., Khaw, K.-T., Kaprio, J., Kaplan, L. M., Johansson, A., Jarvelin, M.-R., Cecile, J. W., Janssens, A., Ingelsson, E., Igl, W., Kees Hovingh, G., Hottenga, J.-J., Hofman, A., Hicks, A. A., Hengstenberg, C., Heid, I. M., Hayward, C., Havulinna, A. S., Hastie, N. D., Harris, T. B., Haritunians, T., Hall, A. S., Gyllensten, U., Guiducci, C., Groop, L. C., Gonzalez, E., Gieger, C., Freimer, N. B., Ferrucci, L., Erdmann, J., Elliott, P., Ejebe, K. G., Doring, A., Dominiczak, A. F., Demissie, S., Deloukas, P., de Geus, E. J. C., de Faire, U., Crawford, G., Collins, F. S., Chen, Y.-D. I., Caulfield, M. J., Campbell, H., Burtt, N. P., Bonnycastle, L. L., Boomsma, D. I., Boekholdt, S. M., Bergman, R. N., Barroso, I., Bandinelli, S., Ballantyne, C. M., Assimes, T. L., Quertermous, T., Altshuler, D., Seielstad, M., Wong, T. Y., Tai, E. S., Feranil, A. B., Kuzawa, C. W., Adair, L. S., Taylor, H. A., Jr., Borecki, I. B., Gabriel, S. B., Wilson, J. G., Holm, H., Thorsteinsdottir, U., Gudnason, V., Krauss, R. M., Mohlke, K. L., Ordovas, J. M., Munroe, P. B., Kooner, J. S., Tall, A. R., Hegele, R. A., Kastelein, J. J. P., Schadt, E. E., Rotter, J. I., Boerwinkle, E., Strachan, D. P., Mooser, V., Stefansson, K., Reilly, M. P., Samani, N. J., Schunkert, H., Cupples, L. A., Sandhu, M. S., Ridker, P. M., Rader, D. J., van Duijn, C. M., Peltonen, L., Abecasis, G. R., Boehnke, M., & Kathiresan, S. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 466(7307), 707–713.PubMedCrossRef

go back to reference Köttgen, A., Pattaro, C., Boger, C. A., Fuchsberger, C., Olden, M., Glazer, N. L., Parsa, A., Gao, X., Yang, Q., Smith, A. V., O’Connell, J. R., Li, M., Schmidt, H., Tanaka, T., Isaacs, A., Ketkar, S., Hwang, S.-J., Johnson, A. D., Dehghan, A., Teumer, A., Pare, G., Atkinson, E. J., Zeller, T., Lohman, K., Cornelis, M. C., Probst-Hensch, N. M., Kronenberg, F., Tonjes, A., Hayward, C., Aspelund, T., Eiriksdottir, G., Launer, L. J., Harris, T. B., Rampersaud, E., Mitchell, B. D., Arking, D. E., Boerwinkle, E., Struchalin, M., Cavalieri, M., Singleton, A., Giallauria, F., Metter, J., de Boer, I. H., Haritunians, T., Lumley, T., Siscovick, D., Psaty, B. M., Zillikens, M. C., Oostra, B. A., Feitosa, M., Province, M., de Andrade, M., Turner, S. T., Schillert, A., Ziegler, A., Wild, P. S., Schnabel, R. B., Wilde, S., Munzel, T. F., Leak, T. S., Illig, T., Klopp, N., Meisinger, C., Wichmann, H. E., Koenig, W., Zgaga, L., Zemunik, T., Kolcic, I., Minelli, C., Hu, F. B., Johansson, A., Igl, W., Zaboli, G., Wild, S. H., Wright, A. F., Campbell, H., Ellinghaus, D., Schreiber, S., Aulchenko, Y. S., Felix, J. F., Rivadeneira, F., Uitterlinden, A. G., Hofman, A., Imboden, M., Nitsch, D., Brandstatter, A., Kollerits, B., Kedenko, L., Magi, R., Stumvoll, M., Kovacs, P., Boban, M., Campbell, S., Endlich, K., Volzke, H., Kroemer, H. K., Nauck, M., Volker, U., Polasek, O., Vitart, V., Badola, S., Parker, A. N., Ridker, P. M., Kardia, S. L. R., Blankenberg, S., Liu, Y., Curhan, G. C., Franke, A., Rochat, T., Paulweber, B., Prokopenko, I., Wang, W., Gudnason, V., Shuldiner, A. R., Coresh, J., Schmidt, R., Ferrucci, L., Shlipak, M. G., van Duijn, C. M., Borecki, I., Kramer, B. K., Rudan, I., Gyllensten, U., Wilson, J. F., Witteman, J. C., Pramstaller, P. P., Rettig, R., Hastie, N., Chasman, D. I., Kao, W. H., Heid, I. M., & Fox, C. S. (2010). New loci associated with kidney function and chronic kidney disease. Nat Genet, 42(5), 376–384.PubMedCrossRef Köttgen, A., Pattaro, C., Boger, C. A., Fuchsberger, C., Olden, M., Glazer, N. L., Parsa, A., Gao, X., Yang, Q., Smith, A. V., O’Connell, J. R., Li, M., Schmidt, H., Tanaka, T., Isaacs, A., Ketkar, S., Hwang, S.-J., Johnson, A. D., Dehghan, A., Teumer, A., Pare, G., Atkinson, E. J., Zeller, T., Lohman, K., Cornelis, M. C., Probst-Hensch, N. M., Kronenberg, F., Tonjes, A., Hayward, C., Aspelund, T., Eiriksdottir, G., Launer, L. J., Harris, T. B., Rampersaud, E., Mitchell, B. D., Arking, D. E., Boerwinkle, E., Struchalin, M., Cavalieri, M., Singleton, A., Giallauria, F., Metter, J., de Boer, I. H., Haritunians, T., Lumley, T., Siscovick, D., Psaty, B. M., Zillikens, M. C., Oostra, B. A., Feitosa, M., Province, M., de Andrade, M., Turner, S. T., Schillert, A., Ziegler, A., Wild, P. S., Schnabel, R. B., Wilde, S., Munzel, T. F., Leak, T. S., Illig, T., Klopp, N., Meisinger, C., Wichmann, H. E., Koenig, W., Zgaga, L., Zemunik, T., Kolcic, I., Minelli, C., Hu, F. B., Johansson, A., Igl, W., Zaboli, G., Wild, S. H., Wright, A. F., Campbell, H., Ellinghaus, D., Schreiber, S., Aulchenko, Y. S., Felix, J. F., Rivadeneira, F., Uitterlinden, A. G., Hofman, A., Imboden, M., Nitsch, D., Brandstatter, A., Kollerits, B., Kedenko, L., Magi, R., Stumvoll, M., Kovacs, P., Boban, M., Campbell, S., Endlich, K., Volzke, H., Kroemer, H. K., Nauck, M., Volker, U., Polasek, O., Vitart, V., Badola, S., Parker, A. N., Ridker, P. M., Kardia, S. L. R., Blankenberg, S., Liu, Y., Curhan, G. C., Franke, A., Rochat, T., Paulweber, B., Prokopenko, I., Wang, W., Gudnason, V., Shuldiner, A. R., Coresh, J., Schmidt, R., Ferrucci, L., Shlipak, M. G., van Duijn, C. M., Borecki, I., Kramer, B. K., Rudan, I., Gyllensten, U., Wilson, J. F., Witteman, J. C., Pramstaller, P. P., Rettig, R., Hastie, N., Chasman, D. I., Kao, W. H., Heid, I. M., & Fox, C. S. (2010). New loci associated with kidney function and chronic kidney disease. Nat Genet, 42(5), 376–384.PubMedCrossRef

go back to reference Kettunen, J., Tukiainen, T., Sarin, A.-P., Ortega-Alonso, A., Tikkanen, E., Lyytikainen, L.-P., Kangas, A. J., Soininen, P., Wurtz, P., Silander, K., Dick, D. M., Rose, R. J., Savolainen, M. J., Viikari, J., Kahonen, M., Lehtimaki, T., Pietilainen, K. H., Inouye, M., McCarthy, M. I., Jula, A., Eriksson, J., Raitakari, O. T., Salomaa, V., Kaprio, J., Jarvelin, M.-R., Peltonen, L., Perola, M., Freimer, N. B., Ala-Korpela, M., Palotie, A., & Ripatti, S. (2012). Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet, 44(3), 269–276.PubMedCrossRef Kettunen, J., Tukiainen, T., Sarin, A.-P., Ortega-Alonso, A., Tikkanen, E., Lyytikainen, L.-P., Kangas, A. J., Soininen, P., Wurtz, P., Silander, K., Dick, D. M., Rose, R. J., Savolainen, M. J., Viikari, J., Kahonen, M., Lehtimaki, T., Pietilainen, K. H., Inouye, M., McCarthy, M. I., Jula, A., Eriksson, J., Raitakari, O. T., Salomaa, V., Kaprio, J., Jarvelin, M.-R., Peltonen, L., Perola, M., Freimer, N. B., Ala-Korpela, M., Palotie, A., & Ripatti, S. (2012). Genome-wide association study identifies multiple loci influencing human serum metabolite levels. Nat Genet, 44(3), 269–276.PubMedCrossRef

go back to reference Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wagele, B., et al. (2011). Human metabolic individuality in biomedical and pharmaceutical research. Nature, 477(7362), 54–60.PubMedCrossRef Suhre, K., Shin, S.-Y., Petersen, A.-K., Mohney, R. P., Meredith, D., Wagele, B., et al. (2011). Human metabolic individuality in biomedical and pharmaceutical research. Nature, 477(7362), 54–60.PubMedCrossRef

go back to reference Nicholson, G., Rantalainen, M., Li, J. V., Maher, A. D., Malmodin, D., Ahmadi, K. R., Faber, J. H., Barrett, A., Min, J. L., Rayner, N. W., Toft, H., Krestyaninova, M., Viksna, J., Neogi, S. G., Dumas, M.-E., Sarkans, U., Donnelly, P., Illig, T., Adamski, J., Suhre, K., Allen, M., Zondervan, K. T., Spector, T. D., Nicholson, J. K., Lindon, J. C., Baunsgaard, D., Holmes, E., McCarthy, M. I., Holmes, C. C., & The Mol, P. C. (2011). A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet, 7(9), e1002270.PubMedCrossRef Nicholson, G., Rantalainen, M., Li, J. V., Maher, A. D., Malmodin, D., Ahmadi, K. R., Faber, J. H., Barrett, A., Min, J. L., Rayner, N. W., Toft, H., Krestyaninova, M., Viksna, J., Neogi, S. G., Dumas, M.-E., Sarkans, U., Donnelly, P., Illig, T., Adamski, J., Suhre, K., Allen, M., Zondervan, K. T., Spector, T. D., Nicholson, J. K., Lindon, J. C., Baunsgaard, D., Holmes, E., McCarthy, M. I., Holmes, C. C., & The Mol, P. C. (2011). A genome-wide metabolic QTL analysis in Europeans implicates two loci shaped by recent positive selection. PLoS Genet, 7(9), e1002270.PubMedCrossRef

go back to reference Barabasi, A.-L., & Oltvai, Z. N. (2004). Network biology: understanding the cell’s functional organization. Nat Rev Genet, 5(2), 101–113.PubMedCrossRef Barabasi, A.-L., & Oltvai, Z. N. (2004). Network biology: understanding the cell’s functional organization. Nat Rev Genet, 5(2), 101–113.PubMedCrossRef

go back to reference Barabasi, A.-L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: a network-based approach to human disease. Nat Rev Genet, 12(1), 56–68.PubMedCrossRef Barabasi, A.-L., Gulbahce, N., & Loscalzo, J. (2011). Network medicine: a network-based approach to human disease. Nat Rev Genet, 12(1), 56–68.PubMedCrossRef

go back to reference Emmert-Streib, F., & Glazko, G. V. (2011). Network biology: a direct approach to study biological function. Wiley Interdiscip Rev Syst Biol Med, 3(4), 379–391.PubMedCrossRef Emmert-Streib, F., & Glazko, G. V. (2011). Network biology: a direct approach to study biological function. Wiley Interdiscip Rev Syst Biol Med, 3(4), 379–391.PubMedCrossRef

go back to reference Keller, B. J., Martini, S., Sedor, J. R., & Kretzler, M. (2012). A systems view of genetics in chronic kidney disease. Kidney Int, 81(1), 14–21.PubMedCrossRef Keller, B. J., Martini, S., Sedor, J. R., & Kretzler, M. (2012). A systems view of genetics in chronic kidney disease. Kidney Int, 81(1), 14–21.PubMedCrossRef

go back to reference He, J. C., Chuang, P. Y., Ma’Ayan, A., & Iyengar, R. (2012). Systems biology of kidney diseases. Kidney Int, 81(1), 22–39.PubMedCrossRef He, J. C., Chuang, P. Y., Ma’Ayan, A., & Iyengar, R. (2012). Systems biology of kidney diseases. Kidney Int, 81(1), 22–39.PubMedCrossRef

go back to reference Schadt, E., Zhang, B., & Zhu, J. (2009). Advances in systems biology are enhancing our understanding of disease and moving us closer to novel disease treatments. Gen, 136(2), 259–269. Schadt, E., Zhang, B., & Zhu, J. (2009). Advances in systems biology are enhancing our understanding of disease and moving us closer to novel disease treatments. Gen, 136(2), 259–269.

go back to reference Ostrowski, J., & Wyrwicz, L. S. (2009). Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Expert Rev Mol Diagn, 9(6), 623–630.PubMedCrossRef Ostrowski, J., & Wyrwicz, L. S. (2009). Integrating genomics, proteomics and bioinformatics in translational studies of molecular medicine. Expert Rev Mol Diagn, 9(6), 623–630.PubMedCrossRef

go back to reference Ideker, T., & Krogan, N. J. (2012). Differential network biology. Mol Syst Biol, 8, 565.PubMedCrossRef Ideker, T., & Krogan, N. J. (2012). Differential network biology. Mol Syst Biol, 8, 565.PubMedCrossRef

go back to reference Schadt, E. E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P. Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C., Zhu, J., Millstein, J., Sieberts, S., Lamb, J., GuhaThakurta, D., Derry, J., Storey, J. D., Avila-Campillo, I., Kruger, M. J., Johnson, J. M., Rohl, C. A., van Nas, A., Mehrabian, M., Drake, T. A., Lusis, A. J., Smith, R. C., Guengerich, F. P., Strom, S. C., Schuetz, E., Rushmore, T. H., & Ulrich, R. (2008). Mapping the genetic architecture of gene expression in human liver. PLoS Biol, 6(5), e107.PubMedCrossRef Schadt, E. E., Molony, C., Chudin, E., Hao, K., Yang, X., Lum, P. Y., Kasarskis, A., Zhang, B., Wang, S., Suver, C., Zhu, J., Millstein, J., Sieberts, S., Lamb, J., GuhaThakurta, D., Derry, J., Storey, J. D., Avila-Campillo, I., Kruger, M. J., Johnson, J. M., Rohl, C. A., van Nas, A., Mehrabian, M., Drake, T. A., Lusis, A. J., Smith, R. C., Guengerich, F. P., Strom, S. C., Schuetz, E., Rushmore, T. H., & Ulrich, R. (2008). Mapping the genetic architecture of gene expression in human liver. PLoS Biol, 6(5), e107.PubMedCrossRef

go back to reference Mirel, B., Eichinger, F., Keller, B. J., & Kretzler, M. (2011). A cognitive task analysis of a visual analytic workflow: exploring molecular interaction networks in systems biology. J Biomed Discov Collab, 6, 1–33.PubMedCrossRef Mirel, B., Eichinger, F., Keller, B. J., & Kretzler, M. (2011). A cognitive task analysis of a visual analytic workflow: exploring molecular interaction networks in systems biology. J Biomed Discov Collab, 6, 1–33.PubMedCrossRef

go back to reference Bergholdt, R., Brorsson, C., Palleja, A., Berchtold, L. A., Fløyel, T., Bang-Berthelsen, C. H., Frederiksen, K. S., Jensen, L. J., Størling, J., & Pociot, F. (2012). Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes, 61(4), 954–962.PubMedCrossRef Bergholdt, R., Brorsson, C., Palleja, A., Berchtold, L. A., Fløyel, T., Bang-Berthelsen, C. H., Frederiksen, K. S., Jensen, L. J., Størling, J., & Pociot, F. (2012). Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes, 61(4), 954–962.PubMedCrossRef

go back to reference Friend, S. H., & Ideker, T. (2011). POINT: are we prepared for the future doctor visit? Nat Biotech, 29(3), 215–218.CrossRef Friend, S. H., & Ideker, T. (2011). POINT: are we prepared for the future doctor visit? Nat Biotech, 29(3), 215–218.CrossRef

go back to reference Kohane, I. S., & Margulies, D. M. (2011). COUNTERPOINT: do not opine before it’s time. Nat Biotech, 29(3), 218–219.CrossRef Kohane, I. S., & Margulies, D. M. (2011). COUNTERPOINT: do not opine before it’s time. Nat Biotech, 29(3), 218–219.CrossRef

go back to reference Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13(11), 2498–2504.PubMedCrossRef Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13(11), 2498–2504.PubMedCrossRef

go back to reference Bhavnani, S., Ganesan, A., Hall, T., Maslowski, E., Eichinger, F., Martini, S., Saxman, P., Bellala, G., & Kretzler, M. (2010). Discovering hidden relationships between renal diseases and regulated genes through 3D network visualizations. BMC Res Notes, 3(1), 296.PubMedCrossRef Bhavnani, S., Ganesan, A., Hall, T., Maslowski, E., Eichinger, F., Martini, S., Saxman, P., Bellala, G., & Kretzler, M. (2010). Discovering hidden relationships between renal diseases and regulated genes through 3D network visualizations. BMC Res Notes, 3(1), 296.PubMedCrossRef

go back to reference Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., Cheng, Y., Clark, M. J., Im, H., Habegger, L., Balasubramanian, S., O’Huallachain, M., Dudley, J. T., Hillenmeyer, S., Haraksingh, R., Sharon, D., Euskirchen, G., Lacroute, P., Bettinger, K., Boyle, A. P., Kasowski, M., Grubert, F., Seki, S., Garcia, M., Whirl-Carrillo, M., Gallardo, M., Blasco, M. A., Greenberg, P. L., Snyder, P., Klein, T. E., Altman, R. B., Butte, A. J., Ashley, E. A., Gerstein, M., Nadeau, K. C., Tang, H., & Snyder, M. (2012). Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell, 148(6), 1293–1307.PubMedCrossRef Chen, R., Mias, G. I., Li-Pook-Than, J., Jiang, L., Lam, H. Y. K., Chen, R., Miriami, E., Karczewski, K. J., Hariharan, M., Dewey, F. E., Cheng, Y., Clark, M. J., Im, H., Habegger, L., Balasubramanian, S., O’Huallachain, M., Dudley, J. T., Hillenmeyer, S., Haraksingh, R., Sharon, D., Euskirchen, G., Lacroute, P., Bettinger, K., Boyle, A. P., Kasowski, M., Grubert, F., Seki, S., Garcia, M., Whirl-Carrillo, M., Gallardo, M., Blasco, M. A., Greenberg, P. L., Snyder, P., Klein, T. E., Altman, R. B., Butte, A. J., Ashley, E. A., Gerstein, M., Nadeau, K. C., Tang, H., & Snyder, M. (2012). Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell, 148(6), 1293–1307.PubMedCrossRef

go back to reference Atkinson, A. J., Colburn, W. A., DeGruttola, V. G., DeMets, D. L., Downing, G. J., Hoth, D. F., Oates, J. A., Peck, C. C., Schooley, R. T., Spilker, B. A., Woodcock, J., Zeger, S. L., & Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther, 69(3), 89–95.CrossRef Atkinson, A. J., Colburn, W. A., DeGruttola, V. G., DeMets, D. L., Downing, G. J., Hoth, D. F., Oates, J. A., Peck, C. C., Schooley, R. T., Spilker, B. A., Woodcock, J., Zeger, S. L., & Biomarkers Definitions Working Group. (2001). Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther, 69(3), 89–95.CrossRef

go back to reference Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., et al. (2010). Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med, 2(46), 46ps42.PubMedCrossRef Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., et al. (2010). Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med, 2(46), 46ps42.PubMedCrossRef

go back to reference Matheis, K., Laurie, D., Andriamandroso, C., Arber, N., Badimon, L., Benain, X., Bendjama, K., Clavier, I., Colman, P., Firat, H., Goepfert, J., Hall, S., Joos, T., Kraus, S., Kretschmer, A., Merz, M., Padro, T., Planatscher, H., Rossi, A., Schneiderhan-Marra, N., Schuppe-Koistinen, I., Thomann, P., Vidal, J.-M., & Molac, B. (2011). A generic operational strategy to qualify translational safety biomarkers. Drug Discov Today, 16(13–14), 600–608.PubMedCrossRef Matheis, K., Laurie, D., Andriamandroso, C., Arber, N., Badimon, L., Benain, X., Bendjama, K., Clavier, I., Colman, P., Firat, H., Goepfert, J., Hall, S., Joos, T., Kraus, S., Kretschmer, A., Merz, M., Padro, T., Planatscher, H., Rossi, A., Schneiderhan-Marra, N., Schuppe-Koistinen, I., Thomann, P., Vidal, J.-M., & Molac, B. (2011). A generic operational strategy to qualify translational safety biomarkers. Drug Discov Today, 16(13–14), 600–608.PubMedCrossRef

go back to reference Hill, A. B. (1965). The environment and disease: association or causation? Proc R Soc Med, 58(5), 295–300.PubMed Hill, A. B. (1965). The environment and disease: association or causation? Proc R Soc Med, 58(5), 295–300.PubMed

go back to reference Slocum, J. L., Heung, M., & Pennathur, S. (2012). Marking renal injury: can we move beyond serum creatinine? Transl Res, 159(4), 277–289.PubMedCrossRef Slocum, J. L., Heung, M., & Pennathur, S. (2012). Marking renal injury: can we move beyond serum creatinine? Transl Res, 159(4), 277–289.PubMedCrossRef

go back to reference Ju, W., Smith, S., & Kretzler, M. (2012). Genomic biomarkers for chronic kidney disease. Transl Res, 159(4), 290–302.PubMedCrossRef Ju, W., Smith, S., & Kretzler, M. (2012). Genomic biomarkers for chronic kidney disease. Transl Res, 159(4), 290–302.PubMedCrossRef

go back to reference Sotiriou, C., & Piccart, M. J. (2007). Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer, 7(7), 545–553.PubMedCrossRef Sotiriou, C., & Piccart, M. J. (2007). Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat Rev Cancer, 7(7), 545–553.PubMedCrossRef

go back to reference Dabbs, D. J., Klein, M. E., Mohsin, S. K., Tubbs, R. R., Shuai, Y., & Bhargava, R. (2011). High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the oncotype DX test: an independent quality assurance study. J Clin Oncol, 29(32), 4279–4285.PubMedCrossRef Dabbs, D. J., Klein, M. E., Mohsin, S. K., Tubbs, R. R., Shuai, Y., & Bhargava, R. (2011). High false-negative rate of HER2 quantitative reverse transcription polymerase chain reaction of the oncotype DX test: an independent quality assurance study. J Clin Oncol, 29(32), 4279–4285.PubMedCrossRef

go back to reference Ignatiadis, M., & Sotiriou, C. (2012). Breast cancer: should we assess HER2 status by Oncotype DX®? Nat Rev Clin Oncol, 9(1), 12–14.CrossRef Ignatiadis, M., & Sotiriou, C. (2012). Breast cancer: should we assess HER2 status by Oncotype DX®? Nat Rev Clin Oncol, 9(1), 12–14.CrossRef

go back to reference Coombes, K. R., Wang, J., & Baggerly, K. A. (2007). Microarrays: retracing steps. Nat Med, 13(11), 1276–1277.PubMedCrossRef Coombes, K. R., Wang, J., & Baggerly, K. A. (2007). Microarrays: retracing steps. Nat Med, 13(11), 1276–1277.PubMedCrossRef

go back to reference Baggerly, K. A., & Coombes, K. R. (2009). Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology. Ann Appl Stat, 3(4), 1309–1334.CrossRef Baggerly, K. A., & Coombes, K. R. (2009). Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology. Ann Appl Stat, 3(4), 1309–1334.CrossRef

go back to reference No authors listed (2010). Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 28(35):5229–5229 No authors listed (2010). Retraction. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer. J Clin Oncol 28(35):5229–5229

go back to reference Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., et al. (2011). Retraction: a genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570–80. New Engl J Med, 364(12), 1176–1176.PubMedCrossRef Potti, A., Mukherjee, S., Petersen, R., Dressman, H. K., Bild, A., Koontz, J., et al. (2011). Retraction: a genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570–80. New Engl J Med, 364(12), 1176–1176.PubMedCrossRef

go back to reference Potti, A., Dressman, H. K., Bild, A., Riedel, R. F., Chan, G., Sayer, R., Cragun, J., Cottrill, H., Kelley, M. J., Petersen, R., Harpole, D., Marks, J., Berchuck, A., Ginsburg, G. S., Febbo, P., Lancaster, J., & Nevins, J. R. (2011). Retraction: genomic signatures to guide the use of chemotherapeutics. Nat Med, 17(1), 135–135.PubMedCrossRef Potti, A., Dressman, H. K., Bild, A., Riedel, R. F., Chan, G., Sayer, R., Cragun, J., Cottrill, H., Kelley, M. J., Petersen, R., Harpole, D., Marks, J., Berchuck, A., Ginsburg, G. S., Febbo, P., Lancaster, J., & Nevins, J. R. (2011). Retraction: genomic signatures to guide the use of chemotherapeutics. Nat Med, 17(1), 135–135.PubMedCrossRef

go back to reference Hayden, E.C. (2012) Lapses in oversight compromise omics results. US board calls for tighter control of test-based data. Nature [23 March 2012]. Hayden, E.C. (2012) Lapses in oversight compromise omics results. US board calls for tighter control of test-based data. Nature [23 March 2012].

go back to reference Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O.M., Dunning, M.J., et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (in press) (Published online, April 18, 2012). Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O.M., Dunning, M.J., et al. (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature (in press) (Published online, April 18, 2012).

go back to reference Monnier, V. M., Vishwanath, V., Frank, K. E., Elmets, C. A., Dauchot, P., & Kohn, R. R. (1986). Relation between complications of type i diabetes mellitus and collagen-linked fluorescence. New Engl J Med, 314(7), 403–408.PubMedCrossRef Monnier, V. M., Vishwanath, V., Frank, K. E., Elmets, C. A., Dauchot, P., & Kohn, R. R. (1986). Relation between complications of type i diabetes mellitus and collagen-linked fluorescence. New Engl J Med, 314(7), 403–408.PubMedCrossRef

go back to reference Sun, J. K., Keenan, H. A., Cavallerano, J. D., Asztalos, B. F., Schaefer, E. J., Sell, D. R., Strauch, C. M., Monnier, V. M., Doria, A., Aiello, L. P., & King, G. L. (2011). Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration. The Joslin 50-Year Medalist Study. Diabetes Care, 34(4), 968–974.PubMedCrossRef Sun, J. K., Keenan, H. A., Cavallerano, J. D., Asztalos, B. F., Schaefer, E. J., Sell, D. R., Strauch, C. M., Monnier, V. M., Doria, A., Aiello, L. P., & King, G. L. (2011). Protection from retinopathy and other complications in patients with type 1 diabetes of extreme duration. The Joslin 50-Year Medalist Study. Diabetes Care, 34(4), 968–974.PubMedCrossRef

go back to reference Mirel, B., Eichinger, F., Nair, V., & Kretzler, M. (2009). Integrating automated workflows, human intelligence and collaboration. Summit on Translat Bioinforma, 2009, 79–83.PubMed Mirel, B., Eichinger, F., Nair, V., & Kretzler, M. (2009). Integrating automated workflows, human intelligence and collaboration. Summit on Translat Bioinforma, 2009, 79–83.PubMed

go back to reference Derry, J. M. J., Mangravite, L. M., Suver, C., Furia, M. D., Henderson, D., Schildwachter, X., Bot, B., Izant, J., Sieberts, S. K., Kellen, M. R., & Friend, S. H. (2012). Developing predictive molecular maps of human disease through community-based modeling. Nat Genet, 44(2), 127–130.PubMedCrossRef Derry, J. M. J., Mangravite, L. M., Suver, C., Furia, M. D., Henderson, D., Schildwachter, X., Bot, B., Izant, J., Sieberts, S. K., Kellen, M. R., & Friend, S. H. (2012). Developing predictive molecular maps of human disease through community-based modeling. Nat Genet, 44(2), 127–130.PubMedCrossRef